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Chapter I 
TREATMENT OF ACUTE PANCREATITIS: AN ONGOING DEBATE 
BETWEEN MEDICAL AND SURGICAL THERAPY 
From a mild self-limiting disease, development of multiple organ failure and 
frequently septic complications towards a fulminant course resistant to any type 
of treatment, acute pancreatitis is a disorder that has numerous causes, an obscure 
pathogenesis and an often unpredictable outcome. 
Following anecdotal reports'-3, acute pancreatitis first became widely recognized 
as a clinical and pathologic condition through an exhaustive review and systematic 
analysis of the course of the disease of 53 patients, reported more than a century 
ago by Reginald Fitz, Professor of Pathological Anatomy at the Harvard 
University'. In contrast to Senn', a Chicago surgeon, he initially considered early 
operative intervention ineffective and hazardous in these patients. Here the debate 
between medical and surgical therapy for acute pancreatitis originates and has 
continued ever since. 
Because acute pancreatitis was usually diagnosed at operation or at autopsy 
during the beginning of the 20th century and a significant proportion of those 
diagnosed at surgery survived, Fitz waived from this conservative stance stating 
that operative intervention would be 'more helpful the earlier in the course of the 
disease it is performed". Moynihan further delineated the surgical approach to 
pancreatitis in 1925 and today his principles of lesser sac debridement and 
drainage remain very nearly the state of the art when it comes to surgery in these 
patients'-'. However due to the introduction of methods for measurements of serum 
amylase and its elevated levels in case of acute pancreatitis, which decreased the 
number of diagnoses made at surgelY, as well as to reports of Mikkelson in 1934 
and Paxton and Payne in 1948, emphasizing a decrease in survival after operative 
management, early surgical intervention was widely regarded as unnecessary or 
harmful lO- 12 • 
Developments in intensive care allowing to safely correct circulatory volume 
and electrolyte disturbances, relief pain, maximize renal perfusion, support 
respiration and provide adequate nutrition, enabled more patients to survive the 
initial critical phase of the disease and further contributed towards this 
conservative treatment. However medical therapies attempting to 'put the pancreas 
at rest' by inhibiting acinar cell secretion with regimens involving nasogastric 
suction [3-15, cimetidine 15-18, atropine 19, glucagon 18,20-22, calcitonin23,24, and 
somatostatin or its analog octreotide25-27 have met with almost uniformly 
disappointing results. Controlled trials with inhibitors of proteolytic enzymes, e.g. 
aprotinin (Trasylol)20.28, gabexate mesilate29•JO , and phosphlipase inhibitors3l , have 
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similarly been ineffective in ameliorating the disease so far. Because few patients 
with severe disease were enrolled in many of these studies, the possibility of not 
reaching statistical significance may have biased the conclusions (type II error)32. 
Triple ostomy a surgical procedure-comprising cholecystostomy, gastrostomy and 
jejunostomy-to relieve the load on the pancreas was reconllllended by Lawson et 
al. 33 . However although a jejunostomy proved useful for quick resumption of 
enteral feeding3• this procedure to rest the inflamed gland, which also included 
closed drainage of the lesser sac, failed to prove its efficacy and gave rise to high 
incidence of septic complications'·'''. Also peritoneal lavage was not found to 
improve the prognosis36•37• In anticipation of future therapies, directed at inhibition 
of intracellular pathological events (e.g. lysosomal enzyme activity/synthesis, 
colocalization ofliposomes and zymogen granules)38, which may possibly become 
available, treatment of patients with acute pancreatitis to day remains largely 
custodial in trying to control presenting symptoms as much as possible. 
In about 20% to 30% of patients with acute pancreatitis a severe clinical course 
arises with development of multiple organ failure and variable amounts of necrosis 
of peri- and pancreatic tissues". With improvement in the early medical 
management of severe acute pancreatitis, secondary infection of the (ped) 
pancreatic necrosis became the leading cause of death in severe acute 
pancreatitis'"'-". During the mid-seventies tln'ee controlled clinical trials, using 
ampicillin, failed to prove efficacy in patients with acute pancreatitis...,-·6. 
Since conservative management failed to decrease the high mortality rate due 
to septic complications in patients with necrotizing pancreatitis, early surgical 
removal of necrosis once again was recalled dudng the early eighties·7•5o• In 1986 
Beger et ai, who performed a prospective bacteriological analysis of necrotic 
tissues obtained at surgery from 114 patients with acute necrotizing pancreatitis, 
demonstrated that infection of (peri)pancreatic necrosis occurs early and 
frequently, causing a significant increase in morbidity and mortality as compared 
to sterile necrosis". Infection of (peri)pancreatic necrosis develops in 40% to 60% 
of patients with severe acute pancreatitis"-". Chances to develop infection of 
necrosis increase with larger amounts of necrosis· '·". In accordance with the adage 
'ubi pus, ibi evacua', infected necrosis was recognized as an absolute indication for 
surgical intervention. A significant contribution has been made by Gerzof et al. by 
introducing the computer tomography-guided percutaneous fine-needle aspiration 
and subsequent culture of (peri)pancreatic necrosis and fluid collections enabling 
early diagnosis of pancreatic infection". However the role of surgery has been 
controversial with regard to sterile necrosis. Since patients with sterile necrosis 
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can do well even without surgery, operative intervention in these patients nowa-
days is limited to those who do not respond to maximal intensive care5%I. 
Despite surgical treatment of necrosis of infected (peri)pancreatic necrosis the 
prognosis remained worse as compared to patients in whom necrosis remained 
sterile. Prophylactic measures, i.e. antibiotics, once again gained interest when 
attention shifted from surgical removal-Le. necrosectomy-of infected necrosis 
towards prevention of infection of necrotic (peri)pancreatic tissues. Although the 
role of bacteria in the induction of experimental acute pancreatitis had been 
extensively examined, little was known about the pathogenesis of secondary 
infection of (peri)pancreatic necrosis. Webster et aI., who firstly demonstrated that 
postinduction bacteremia is an important phenomenon in experimental acute 
pancreatitis, suggested that local infectious complications Oliginate from 
hematogenous seeding". Because microbiological analysis of infected (peri) 
pancreatic necrosis, both experimentally and clinically, revealed mostly gram-
negative aerobic micro-organisms which showed a resemblance with the intestinal 
flora, the gut was postulated as their possible origin8.9.51-53.62-65. Raised titres of 
antibodies against enterobacterial common antigen, which indicate the humoral 
antibody response against enteric bacteria, further supported the hypothesis that 
these micro-organisms may possibly originate from the intestine from which they 
trans locate towards the necrosis66• 
In 1987 Lange et al. showed in a controlled study of experimental acute 
pancreatitis in rats, that reduction of intestinal flora, by means of either subtotal 
colectomy or intestinal lavage and intraluminal instillation of kanamycin both 
resulted in a reduction of mortality. However in the colectomized rats gram-
negative bacteraemia was not prevented, suggesting incomplete reduction of 
intestinal flora as compared to the lavaged rats in which gram-negative micro-
organisms were absent both in blood as well as ascites6'. 
A pilot study was conducted in patients with severe acute pancreatitis using 
intestinal lavage. However the application of this technique did impose us with 
severe logistic problems and resulted in undesirable dyscomfort for the patient 
(Lange JF, unpublished data). 
A clinical feasible way to effectively reduce the aerobic gram-negative intestinal 
flora was reported for the first time in 1984 by Stoutenbeek et al. with their use of 
selective decontamination of the digestive tract6S • In this teclmique non-absorbed 
antibiotics are employed to eliminate or greatly reduce the number of aerobic 
gram-negative bacilli and yeasts in the gastrointestinal tract (thus reducing the risk 
of endogenous infection), whilst retaining the normally predominant anaerobic 
flora (thereby preventing colonization or overgrowth with drug-resistant strains, 
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a phenomenon termed colonization resistancej69,70, The prophylactic strategy 
combined tln'ee distinct components: SDD applied to the patients tln'oughout their 
rcu stay, systemic cefotaxime administered for the first few days only and 
intensive microbiological surveillance, SDD was supplemented with cefotaxime 
for a/ell' days to provide additional broad-spectrum cover for the early petiod of 
admission when SDD is only partially established, Cefotaxime has negligible 
effects on the anaerobic flora of the gastrointestinal tract and is thus unlikely to 
hamper resistance to colonization7!, 
Since infection of (perijpancreatic necrosis emerged as the principal determinant 
for survival in the patient with severe acute pancreatitis surviving the early phase 
of the disease and aerobic gram-negative micro-organisms, possibly originating 
from the digestive tract based on resemblance, are most frequently isolated, 
selective decontamination of the digestive tract was investigated as a prophylactic 
strategy, After all, increasing the proportion of patients in whom (perijpancreatic 
necrosis is precluded from secondary infection may lead to reduction of mortality 
as depicted in the hypothesis given below, 
HYPOTHESIS 
Severe acute pancreatitis 
1 
Selective decontamination of the digestive tract 
1 
Elimination and prevention of acquisition of 
aerobic gram-negative intestinal micro-organisms 
1 
Preservation of sterile (perijpancreatic necrosis 
1 
Reduction of mortality? 
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AIM OF THE STUDY 
Selective decontamination of the digestive tract was used as an prophylactic 
strategy in a multicenter controlled clinical trial in patients with severe acute 
pancreatitis in order to evaluate the following issue: 
I) Does the use of selective decontamination reduce mortality in patients with 
severe acute pancreatitis? 
2) Does the use of selective decontamination reduce aerobic gram-negative 
infection of (peri)pancreatic necrosis in patients with severe acute 
pancreatitis? 
3) Does aerobic gram-negative colonization of the digestive tract lead to an 
increased risk of aerobic gram-negative pancreatic infections and is tills event 
time related? 
4) Does the difference in the quantity and quality of nllcro-organisms, colonizing 
the digestive tract, influence morbidity and mortality of severe acute 
pancreatitis? 
5) Does the use of selective decontanllnation reduce intestinal colOlllzation with 
aerobic gram-negative nllcro-organisms in patients with severe acute 
pancreatitis? 
6) Is the prognosis dependent on the different bacteriological status of (peri) 
pancreatic necrosis, i.e. development of gram-negative and/or gram-positive 
infection as compared to preservation of sterile necrosis? 
7) Is there a reduction in morbidity when infection of the necrosis can be 
prevented? 
14 
introdllclioll 
REFERENCES 
1. Aubert 1. Progyannasmata (1579). Lowndes S. Adenochoiradelogia, or exact anatomical 
treatise of the glandules. London 1684: 142-143. 
2. Clasen A. Die Krankh.D.Bauchspeicheldr.1842. 
3. Fliedreich P. Disease of the pancreas. Ziemssen A. Cyclopedia of the practice of medicine. 
New York, William Wood 1878;8:551-630. 
4. Fitz RH. Acute pancreatitis, a consideration of pancreatic hemon'hage, hemorrhagic, 
suppurative, and gangrenous pancreatitis, and of disseminated fat necrosis. Boston Med Surg 
J 1889;70:181-235. 
5. Senn N. The surgelY of the pancreas. Trans Am Surg Assoc 1886;4:99-225. 
6. Fitz RH. The symptomatolgy and diagnosis of diseases of the pancreas. Proc NY Path Soc 
1898;43: 1-26. 
7. Moynihan B. Acute pancreatitis. Ann Surg 1925;81:132-142. 
8. Bradley EL III. Management of infected pancreatic necrosis by open drainage. Ann Surg 
1987;206:542-550. 
9. Warshaw AL, Jin G. Improved survival in 45 patients with pancreatic abscess. Ann Surg 
1985;202:408-415. 
10. Elman R, Amcson N, Graham EA. Value of blood amylase estimations in the diagnosis of 
pancreatic disease. Arch Surg 1929;19:943-967. 
II. Mikkelson D. Pancreatitis acuta. Acta Chir Scand 1934;75:373. 
12. Paxton JR, Payne JR. Acute pancreatitis: a statistical review of 307 established cases of 
acute pancreatitis. Surg Gynecol Dbstet 1948;86:69. 
13. FUller RK, Loveland JP, Frankel MH. An evaluation of the efficacy of nasogastric suction 
treatment in alcoholic pancreatitis. Am J GastroenteroI1981;75:349-353. 
14. Sail' MGR, Sanfey JL, Cameron JL. Prospective, randomized trial of nasogastric suction in 
patients with acute pancreatitis. Surgery 1986; 100:500-504. 
15. Loiudice TA, Lang J, Mehta H, Banta L. Treatment of acute alcoholic pallcreatitis: the roles 
of cimetidine and nasogastric suction. Am 1 Gastroenterol 1984; 79:553-558. 
16. Meshkinpour J, Molinati MD, Gardner L et a1. Cimetidine in the treatment of acute 
alcoholic pancreatitis: a randomized, donble blinded study. Gastroenterology 1979;77: 687-
690. 
17. Brae PJ, Zinner MJ, Cameron JL. A clinical trial of cimetidine in acute pancreatitis, Surg 
Gynecol Dbstet 1982; 154: 13-16. 
18. Regan PT, Malagelada JR, Go VLW, et al. A prospective study of the antisecretOlY and 
therapeutic effects of cimetidine and glucagon in human acute pancreatitis. Nlayo Clill Proe 
1981;56:499-503. 
19. Cameron JL, Mehigan D, Zuidema GD. Evaluation of atropine in acute pancreatitis. Surg 
Gynecol Dbstet 1979;148:206-208. 
20. \Velbourn RB, Armitage P, Gilmore OJA, et al. Medical Research Council of the United 
Kingdom: Death from acute pancreatitis: multicelltre trial of glucagon and aprotinin. Lancet 
1977;2 :632-635. 
21. DUn HK, Maroske D, Zedler D, Bode Je. Glucagon therapy in acute pancreatitis. Gut 
1978; 19: 175-179. 
15 
Chapter 1 
22. Kronberg 0, Biilow S, Joergensen PM, Svendsen LB. A randomized controlled trial of 
glucagon in the treatment of first attack of severe acute pancreatitis without associated 
biliary disease. Am J Gastroenterol 1980;73:423-425. 
23. Paul F, Ohnhaus EE, Hesch RD. Einfluss van Salmcalcitonin auf def Verlauf def a1.'Uten 
pancreatitis. Dtsch Med Wochenschr 1979;104:615-622. 
24. Goebell H, Ammann R, Helfarthe C. A double blind trial of synthetic salmon calcitonin in 
the treatment of acute pancreatitis. Scalld J Gastroenterol 1979; 14:881-889. 
25. Usadel KH, Uberla KK, Leuschner U. Treatment of acute pancreatitis with somatostatin: 
resuits of a multicenter double blind tria!. Dig Dis Sci 1985;30:992. 
26. D!Amico D. Favia G, Biasiato R, et al. The use of somatostatin in acute pancreatitis: results 
of a muiticenter Itia!. Hepatogastroenterology 1990; 37:92-98. 
27. :McKay el, Inule C'V, Baxter IN. Somatostatin and somatostatin analogues - are they 
indicated in the management of acute pancreatitis? Gut 1993;34: 1622-1626. 
28. Inuie C\V, Benjam.in IS, Ferguson JC. A single centre double blind trial of trasylol therapy 
in primary acute pancreatitis. Br J Surg 1978;65:337-341. 
29. Yang CY, Chang-Chien CS, Liaw YF. Controlled trial of protease inhibitor gabexelate 
mesHate (FOY) in the treatment of acute pancreatitis. Pancreas 1987;2:698-700. 
30. BUchler M, Malfertheiller P, Waldemar D, et a1. Gabexate mesilate in human acute 
pancreatitis. Gastroenterology 1993; I 04: 1165-1170. 
31. Tykka HTEJ, Vaittinen KL, Mahlberg JE, et al. A randomized double blind study using 
CaNa1EDTA, a phospholipase Al inhibitor, in the management of human acute pancreatitis. 
Scand J GastroenteroI1985;20:5-12. 
32. Tenner S, Banks PA. Acute pancreatitis: nonsurgical management. World J Surg 
1997;21: 143-148. 
33. Lawson DW, Daggett \VM, Civetta JM,et a1. Surgical treatment of acute necrotizing 
pancreatitis. Ann Surg 1970;172:605-617. 
34. Hesselink EJ, Siooff MJ, Bleichrodt RP, Van Schilfgaarde R. Conservative surgical 
treatment for acute pancreatitis: the Lawson procedure. Neth J Surg 1987;39:79-82. 
35. McCarthy MC, Dickerman RNI. Surgical management of severe acute pancreatitis. Arch 
Surg 1982;117:476-480. 
36. Mayer AD, McMahon MJ, Corfield AP, et a1. Controlled clinical trial of peritoneal1avage 
for the treatment of severe acute pancreatitis. N. Engl J Med 1985;312:399-404. 
37. lllse I, Evander A, Holmberg JT, Gustafson I. Influence of peritoneal lavage on objective 
prognostic signs in acute pancreatitis. AIm Surg 1986;204:122-127. 
38. Bilchik AJ, Zucker K, Adrian TE, Modlin It\1. Amelioration of cholinergic-induced 
pancreatitis with a selective cholecystokinin receptor antagonist. Arch Surg 1990;125:1546-
1549. 
39. Ashley SW, Reber HA. Clinically based classification system for acute pancreatitis. 
Pancreas 1993;8:738-741. 
40. Buggy BP, Nostrant IT. Lethal pancreatitis. Am J Gastroenterol1983; 78:810-814. 
41. Ranson JHC, Balthazar E, Caccavale R, Cooper M. Computed tomography and the 
prediction of pancreatic abscess in acute pancreatitis. Ann Surg 1985;201:656-665. 
42. Renner IG, Savage WT ill, Pantoja JL, Renner VJ. Death due to acute pancreatitis: a 
retrospective analysis of 405 autopsy cases. Dig Dis Sci 1985;30:1005-1018. 
16 
Introduction 
43. Kivilaakso E, Lempinen M, Makelainen A, et a1. Pancreatic resection versus peritoneal 
lavation for acute fulminant pancreatitis. Ann Surg 1984;199:426-431. 
44. Howes R, Zuidema GD, Cameron JL. Evaluation of prophylactic antibiotics in acute 
pancreatitis. 1 Surg Res 1975;18:197-200. 
45. Craig RM, Dordal E, Myles L. The use of ampicillin in acute pancreatitis. Ann Int Med 
1975;83:831-832. 
46. Finch WT, Sawyers 11., Schenker S. A prospective study to determine the efficacy of 
antibiotics in acnte pancreatitis. Ann Surg 1976;183:667-671. 
47. Alexandre JH, Guerrieri MT. Role of total pancreatectomy in the treatment of necrotizing 
pancreatitis. World 1 Snrg 1981;5:369-377. 
48. Frey CF. Hemorrhagic pancreatitis. Am 1 Surg 1979;137:616-623. 
49. KUmmerle F, Neher M. Management of complications after operations for acute pancreatitis. 
World 1 Surg 1981;5:387-392. 
50. Autio V, Juusela E, Lauslati K, et a1. resection of the pancreas for acute hemorrhagic and 
necrotizing pancreatitis. World 1 Surg 1979;3:631-639. 
51. Beger HO, Bittner R, Block S, BUchler M. Bacterial contamination of pancreatic necrosis: 
a prospective clinical study. Gastroenterology 1986;91 :433-438. 
52. Gerzof SG, Banks PA, Vesentini S, et al. Early diagnosis of pancreatic infection by 
computer tomography-guided aspiration. Gastroenterology 1987;93: 1315-1320. 
53. Bittner R, Block S, BUchler M, Beger BO. Pancreatic abscess and infected pancreatic 
necrosis. Different local septic complications in acute pancreatitis. Dig Dis Sci 1987;32: 
1082-1087. 
54. Beger HO, BUchler M, Bittner R, et al. Necrosectomy and postoperative local lavage in 
necrotizing pancreatitis. Br 1 Surg 1988; 75:207-212. 
55. Warshaw AL. Inflammatory masses following acute pancreatitis. Phlegmon, pseudocysts 
and abscess. Surg Clln North Am 1974;54:621-636. 
56. Bassi C, Falconi M, GireIli R, et al. Microbiological findings in severe acute acute 
pancreatitis. Surg Res CommunI989;5:1-4. 
57. Smadja C, Bismuth B. Pancreatic debridement in acute necrotizing pancreatitis: an obsolete 
procedure? Br 1 Surg 1986;73:408-410. 
58. Beger HO, Krautzberger W, Bittner R, et a1. Results of surgical treatment of necrotizing 
pancreatitis. World 1 Surg 1985;9:972-979. 
59. Bradley EL III, Allen K. A prospective longitudinal study of observation versus surgical 
intervention in the management of necrotizing pancreatitis. Am J Surg 1991;161:19-25 
60. Rau B, Pralle V, Vhl 'V, et a1. Management of sterile necrosis in instances of sever acute 
pancreatitis. 1 Am Coli Surg 1995;181:279-288. 
61. Rattner DW, Legermate DA, Lee Ml, et al. Early surgical debridement of symptomatic 
pancreatic necrosis is beneficial irrespective of infection. Am J Surg 1992; 163: 1 05-11 O. 
62. \Vebster:MW, Pasculle A \V, Myerowitz RL, et al. Postinduction bacteremia in experimental 
pancreatitis. Am 1 SurgI979;138:418-420. 
63. Teerenhovi 0, Nordback I, Isolauri J, Auvinen O. Pancreatic renmant abscess after resection 
for acute necrotizing pancreatitis. Int Surg 1988; 73: 137-139. 
64. Pederzoli P, Bassi C, Vesentini S, et a1. Retroperitoneal and peritoneal drainage and lavage 
in the treatment of severe necrotizing pancreatitis. Surgery 1990; 170: 197-203. 
17 
Chapter 1 
65. Lumsden A, Bradley EL IIT. Secondary pancreatic infections. Surg Gynecol Obstet 
1990;170:459-467. 
66. Kivilaakso E. Valtonen VV, Malkurnaki M, et al. Elldotoxaemia and acute pancreatitis: 
correlation between severity of the disease and the anti-enterobacterial common antigen 
antibody titre. Gut 1984;25:1065-1070. 
67. L1uge JF, van Goal J, Tytgat GNJ. The protective effect of a reduction in intestinal flora on 
mortality of acute haemonhagic pancreatitis in the rat. Hepato-gastroenterol1987;34:28-30. 
68. Stoutenbeek ChP, van Saene HKF, Miranda DR, Zandstra DF. The effect of selective 
decontamination of the digestive tract on colonization and infection rate in multiple trauma 
patients. Intensive Care Med 1984;10: 185-192. 
69. Van del' Waaij D, Berghuis-de Vries 1M, Lekkerkerk-vull der Wees J. Colonization 
resistance of the digestive tract in conventional and antibiotic treated mice. J Hyg Camb 
1971 ;69:405-411. 
70. van Saene HKF, Stoutenbeek ChP. Selective decontamination. J Antimicrobial Chemother 
1987;20:462-465. 
71. Vollaard EJ, C1asener HAL, Janssen AJHM, Wynne HJA. Influence of cefotaxime on 
microbial colonization resistance in healthy volunteers. J Antimicrob Chemother 1990; 
26:117-123. 
18 
CHAPTER 2 
CONTROLLED CLINICAL TRIAL OF SELECTIVE DECONTAMINATION 
FOR THE TREATMENT OF SEVERE ACUTE PANCREATITIS 
Ernest IT. Luiten, Wim C.J. Hop, Johan F. Lange, Hajo A. Bruining 
Adapted/rom the publication in Ann Surg 1995;222:57-65 
19 
Chapter 2 
ABSTRACT 
Secondary infection of (peri)pancreatic necrosis is the major cause of death in 
patients with severe acute pancreatitis. Controlled clinical trials to study the effect 
of selective decontamination in such patients are not available. A randomized 
controlled multicenter trial was undertaken in 102 patients with objective evidence 
of severe acute pancreatitis to evaluate whether selective decontamination (SD) 
reduces mortality. 
Between April 22, 1990 and April 19, 1993, 102 patients with severe acute 
pancreatitis were admitted to 16 participating hospitals. Patients were entered into 
the study if severe acute pancreatitis was indicated, on admission, by multiple 
laboratory criteria (Imrie score ;003) and/or computed tomography criteria 
(Balthazar grade D or E). Patients were randomly assigned to receive standard 
treatment (control group) or the same standard treatment plus selective 
decontamination (SD group). All patients received full supportive treatment and 
surveillance cultures were taken in both groups. 
Fifty patients were assigned to the SD group and 52 were assigned to the control 
group. There were 18 deaths in the control group (35%), compared with 11 deaths 
(22%) in the SD group. (adjusted for Imrie score and Balthazar grade: p=0.048). 
This difference was mainly caused by a reduction oflate mortality (>2 weeks) due 
to significant reduction of gram-negative pancreatic infection (p=0.003). The 
average number of laparotomies per patient was reduced in patients treated with 
SD (p<0.05). Failure of SD to prevent secondary gram-negative pancreatic 
infection with subsequent death was seen in only three patients (6%) and transient 
gram negative pancreatic infection in one (2%). In both groups of patients, all 
gram-negative aerobic pancreatic infection was preceded by colonization of the 
digestive tract by the same bacteria. 
Reduction of gram-negative colonization of the digestive tract, preventing 
subsequent pancreatic infection by means of selective decontamination, 
significantly reduces morbidity and mortality in patients with severe acute 
pancreatitis. 
INTRODUCTION 
DESPITE improvement in surgical strategies, the mortality of patients with acute 
necrotizing pancreatitis remains high, between 20 to 70 %1.8. Infection of 
pancreatic necrosis is the most important cause of late mortality in severe acute 
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pancreatitis3,7,9-13, The value of prophylactic antibiotics has not been clearly 
demonstrated in patients with severe acute pancreatitis and possibly is due to 
patient selection, inadequate spectl'llm, insufficient doses or tissue 
penetrationI2,14-17. Intravenous antibiotics, which penetrate the pancreas-blood 
barrier, may not protect the necrotic nonperfused areas in and around the inflamed 
pancreas against infection, 
The route by which sterile pancreatic necrosis becomes infected is not yet 
known, Experimental studies and clinical observations have suggested that 
translocation of bacteria toward the pancreas occurs hematogenouslyI8,19, 
transmurally through the colon2O-22, via lymphogenous routes'O,2l, via ascites I9,23, 
and through bile'4, and duodenal chyme reflux", Because gram-negative bacteria-
predominantly isolated from the pancreatic necrosis-are of enteric origin, it seems 
probable that the source of the translocating bacteria is the intestine2,7,9,1O,14,22,23,26,27, 
Prevention of translocation by intraluminal elimination of aerobic gram-negative 
micro-organisms in the intestinal tract may be an effective method to prevent 
pancreatic necrosis from becoming infected, In a controlled experimental study on 
rats with bile-salt-induced pancreatitis Lange et al. demonstrated a significant 
reduction of mortality in rats treated with intestinal lavage and intraluminal 
instillation of kanamycin 19. Isaji et al. recently demonstrated in mice fed a choline-
deficient, ethionine-supplemented diet to induce pancreatitis that oral antibiotics 
caused a three-fold reduction of infected necrosis and a significantly improved 
survival" . 
Several clinical studies have demonstrated that selective decontamination 
effectively eliminates aerobic gram-negative bacteria from the intestinal tract and 
sometimes reduces gram-negative septic complications in intensive care unit 
patients, However, resnlts regarding reduction of mortality are conflicting"-34. This 
randomized, controlled clinical trial was undertaken to evaluate whether selective 
decontamination reduces mortality in patients with objective evidence of severe 
acute pancreatitis, 
PATIENTS AND METHODS 
Patients 
Between April 22, 1990 and April 19, 1993, 102 patients with objective clinical 
signs of severe acute pancreatitis were admitted to 16 participating hospitals, The 
diagnosis of acute pancreatitis had been established on the basis of clinical 
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examination and elevated plasma levels of amylase (> 1000 IV per liter), or at 
diagnostic laparotomy (ten patients). All patients were scored according to a 
multiple laboratory criteria score (Imrie score)35 and contrast-enhanced computed 
tomography (CE-CT) examinations were used to classify disease severity 
(Balthazar grades)J6 (Table 1) within 48 hours of hospital admission. 
Table 1. Prognostic Systems Used to Select Patients for Inclusion in the Trial 
Multiple Laboratory Criteria (Imrie score)' 
Age > 55 years 
Semm uncorrected calcium 
Serum urea 
< 2.00 mmoJIl 
> 16 1l11l1oll1 
> 600 VII Lactate dehydrogenase 
Blood glucose (no diabetes) 
White cell count 
> ]0 mlllolll 
> 15 ]0'/1 
<32 gil Serum albumin 
Pa02 < 60 mm Hg (7.5 kPa) 
Degree of disease severity according to Balthazar c1assification+ 
grade A 
grade B 
grade C 
grade D 
grade E 
normal pancreas 
focal or diffuse enlargement of the pancreas (including contour inegularities, 
nonhomogeneous attenuation of the gland, dilatation of the pancreatic duct, 
and foci of small fluid collections within the gland, as long as there is no 
evidence of peripancreatic disease) 
intrinsic pancreatic abnormalities associated with haziness and streaky 
densities representing inflammatory changes in the peripancreatic fat 
as C pIns single ill-defined fluid collection (phlegmon) in or adjacent to the 
pancreas 
as C plus two or multiple, poorly defined fluid collections or the presence of 
gas in or adjacent to the pancreas 
* : The lilllie score equals the number of separate ctitelia present (minimum: 0 ; maximum: 8). + : CT scan with use of oral (112 hr before) and intravenous contrast (rapid iv drip). Pa02 = 
arterial oxygen concentration. 
Patients were included in the study if the following criteria were met: severe acute 
pancreatitis was indicated by 3 or more points according to the Inule score andlor 
CT findings corresponding with Balthazar grade D or E. Findings at diagnostic 
laparotomy were not accepted as an inclusion critera. 
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Exclusion criteria were defined as follows: allergy to one of the antibiotics of the 
SD regimen; younger than 18 years of age; postoperative pancreatitis after 
pancreatic surgelY; and bacteriologically proven infected necrosis at the time of 
randomization. The attending clinician obtained informed consent from the patient 
or relatives. 
Patients who satisfied the criteria were randomly assigned to receive standard 
treatment (control group) or the same standard treatment plus selective 
decontamination (SD group). A 24-hour randomization service was available to 
randomize patients with stratification per center. Follow-up CT scans were 
repeated every week until discharge or death. The study was approved by the 
ethics cOllllluttees of the participating hospitals. 
Control Group: Standard Treatment 
A nasogastric tube was always inserted. Intravenous crystalloid solutions were 
given according to clinical requirements. Oxygen therapy, based on arterial blood 
gas analysis, was administered by face mask and was replaced by assisted 
ventilation if the patient developed respiratory insufficiency. Cultures from the 
oropharynx, rectum, sputum, gastric content, and urine were taken on adnussion 
to the hospital and twice a week until discharge. If fever (z39°C) was present, 
blood cultures were taken. Except for urine, qualitative semiquantitative 
bacteriologic analysis was pelformed routinely on all cultures. Cultures of 
(peri)pancreatic necrosis and ascites were obtained at laparotomy or by means of 
ultrasonographic or CT -guided percutaneous puncture, as described by Gerzoff et 
al. lO, if there was clinical suspicion of infected pancreatic necrosis. Patients 
underwent surgery if an ultrasonographlc or CT -guided puncture showed presence 
of bacteria or if the condition was deteriorating despite aggressive supportive 
treatment. Surgely was performed either by transverse or median laparotomy. If 
repeated laparotonues were foreseen, a laparostomy, i.e. a ventral open packing 
of the abdominal cavity, was created'. Antibiotics were prescribed according to the 
antibiogram only in the presence of conCUl1"ent infection. Enteral feeding was 
replaced by total parenteral nutrition only if recurrent gastric retention was 
present. 
SD group: Standard Treatment with Adjuvant Selective Decontamination 
Patients randomized to the SD group received the same treatment as the control 
group with the addition of selective decontanunation (SD). The SD regimen 
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consisted of oral administration of colistin-sulfate (200 mg), amphotericin 
(500 mg) and norfloxacin (NoroxinR 50 mg) every 6 hours. A sticky paste 
containing 2% of the three SO dl1lgs was smeared along the upper and lower gums 
evelY 6 hours and at the tracheostomy, if present. The aforementioned daily dose 
also was given in a rectal enema every day. A short-term systemic prophylaxis 
(mean 7.4 days) of cefotaxim sodium (ClaforanR 500 mg) evelY 8 hours was given 
until gram-negative bacteria were eliminated from the oral cavity and rectum. SO 
was discontinued as soon as the risk of aquiring a new infection was absent-i.e., 
the patient was extubated and without supplementmy oxygen therapy or infusions, 
on regular oral diet, and mobilized on the ward. 
Statistical Analysis 
Power calculations at the phase of trial design, assuming a decrease in mortality 
from 50% to 25%, led to a total number of 154 patients to be included (alpha=0.05 
(two-sided) and beta=O.lO). 
Because the annual accrual rate was much less than expected, after 2 years it 
was decided to limit the size of the trial to 100 evaluable patients, thereby reducing 
the power to 80% at one-sided testing. This decision was made without 
consideration of the accumulating outcomes. 
Percentages were compared by the Fisher exact test or the chi square test, if 
appropriate. Continuous data were compared by the Mann-Whitney U test. For 
mortality, which was the major end-point in this study, multivariate analysis 
(logistic regression37) at entry into the study, allowing for Imrie score and 
Balthazm' grade, was pelformed to obtain a higher level of precision in comparing 
treatment groups. Two-sided p values of 0.05 or less were considered statistically 
significant. Follow-up was continued until death or discharge from the hospital. 
RESULTS 
Inclusious, Exclusions, and Withdrawals 
Of the 109 patients randomized into the study 2 (SO: n=1 ; control: n=l) were 
excluded because of peroperatively proven infected necrosis inmlediately (<1hr) 
after randomisation and before treatment was started. In addition, five patients 
(SO: n=3; control: n=2) were withdrawn from the study because the clinical 
diagnosis was found to be en'oneous (one patient with streptococcal sepsis, one 
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patient with an acute aortic occlusion inullediately after coronary bypass surgery, 
one patient with a mptured pancreatic pseudocyst, one patient with cln'onic 
pancreatitis and one patient with an ERCP-induced choledochus perforation). 
Table 2. Baseline characteristics of Patients with Severe Acute Pancreatitis 
SD group Control group 
(n=50) (n=52) 
Mean age (range) 56 (26-91) 55 (20-88) 
Sex 
Male 31 29 
Female 19 23 
Etiology 
Alcohol 19 12 
Gallstones 17 19 
Hyperparathyroidism 0 2 
Blunt abdominal trauma I 0 
Postoperative 2 2 
ERCP' - induced I 3 
Unknown 10 14 
Imrie score 
0 5 4 
1 8 7 
2 2 10 
3 10 6 
4 12 13 
5 9 6 
6 3 2 
7 I 4 
8 0 0 
Balthazar degree of disease severity 
grade A 0 0 
grade B 0 0 
gradeC 3 4 
gradeD 21 20 
grade E 26 27 
day 1 unavailable 0 I' 
+ : ERCP = endoscopic retrograde cholangiopancreatography 
* : CT -scan was performed on day 5 : grade D 
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Of the remaining 102 patients, 50 had been assigned to the SD group and 52 to the 
control group. Inclusion scores are listed in Table 2. Selective decontamination 
was started within 24 hI's of randomization. Ten patients (SD: n=8 ; control: n=2) 
with severe acute pancreatitis had to be randomized only on the basis of the 
multiple laboratory criteria (Imrie score ~3) as their condition did not permit 
transport from the intensive care unit to the CT scanner at that time. Of these 
patients, fluid collections in or adjacent to the severely inflamed pancreas 
(personal communication with the atttending surgeon immediately post-
operatively) were demonstrated on the first day of the study during laparotomy in 
eight patients and with abdominal ultrasound in one patient. Because of these 
results, the Balthazar grade was classified as grade E. In the other patient (control 
group; Imrie score=3), a CT scan was pelfOlmed only after five days of treatment 
and it demonstrated a peripancreatic fluid collection. The latter patient also 
underwent surgery on the first day after randomization; however, the pancreatic 
loge was left untouched. The Balthazar grade at the time of randomization was 
unavailable for this patient. 
Comparability of Control and SD group 
Both treatment groups appeared well matched for age, sex, etiologic factors, Imrie 
score, and Balthazar grade. Characteristics for both groups are listed in Table 2. 
The mean Imrie score was 3.2 for both groups. Patients with an Inn'ie score of 8 
were not encountered in this study. 
Mortality 
Eleven patients (22%) in the SD group died as compared to 18 patients (35%) in 
the control group. This difference is not significant (p=0.19). The 95% confidence 
limits of the difference (control group minus SD group) in mortality ranges from 
less than 4% to more than 30%. Survival according to treatment group is shown 
in Figure I. All deaths occun'ed within 80 days. In each of both groups 6 patients 
died of multiple-organ failure with documented sterile pancreatic necrosis. Ten 
patients in the control group died of a gram-negative pancreatic sepsis syndrome 
compared with only tln'ee such patients in the SD group (p=0.07). In each of both 
groups one patient died of sepsis due to a solitary gram-positive pancreatic 
infection. Gram-positive sepsis of unknown origin, without pancreatic infection, 
was the cause of death in one patient in each of both groups. 
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The Inu'ie score at entty into the study appeared to correlate velY strongly with 
mortality (Figure 2). Mortality was 0% for an lnu'ie score of 0 or I, and gradually 
increased to 100% for patients with an Imrie score of 7 (p","d<O.OOI). Mortality 
also increased with increasing Balthazar grade, although these differences were 
less pronounced (p'",d=0.04) (Figure 2). The worsening of prognosis with 
increasing Inu'ie score and Bathazar grade was apparent in each separate treatment 
group. Overall mortality in the SD group versus the mOitality in the control group 
appeared to be significantly lower (p=0.048), using multivariate analysis allowing 
for lnu'ie score and Balthazar grade (Table 3). This analysis also demonstrates the 
importance of the Imrie score in predicting mortality. There was no significant 
relation between mortality and the Balthazar grade. 
1.00 -
jj' 0.75-
·n 
~ 
n 
ro 
n 
o {£ 0,50-
rl 
ro 
> 
·n 
> 
c 
~ 0,25-
-- Selective Decontamination group 
- - - - - Control group 
0.00 - '------------------
gb 
day 
Figure 1. Overall survival according to treatment. Overall mortality rates at 90 days: SD 
group=22% ; control group=35%. Adjusted for Itmie score and Balthazar grade, p=O.048. 
Difference in mortality rates equals 13% (95% confidence limits: -4%, +30%). 
Bacteriologic analysis 
Secondary pancreatic infection occurred in 20 patients (38%) in the control group 
and in 9 patients (18%) of the SD group (p=0.03). Gram-negative pancreatic 
infection occurred in 17 patients (33%) in the control group and in only 4 patients 
(8%) in the SD group (p=0.003). Pancreatic necrosis was not infected in II of 16 
patients who died early in contrast to only 3 of 13 patients who died after 2 weeks 
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(p=0.03). This difference is similar for both groups. Qualitative bacteriologic 
analysis of (peri) pancreatic necrosis for both groups is demonstrated in Table 4. 
Of74 bactetial colonies isolated from 20 patients of the control group 61 % were 
aerobic gram-negative pathogens. Of 28 colonies isolated from nine patients of the 
SD group 21 % were aerobic gram-negative. Any case of gram-negative pancreatic 
infection was preceded by intestinal colonization with identical gram-negative 
flora in both groups, as lea1'lled from surveillance cultures of the digestive tract. 
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Figure 2. Survival according to an Imrie score of Oil (n=24), 2 (n=12), 3 (n=16), 4 (n=25), 5 
(n=15), 6 (n=5), and 7 (n=5), respectively (upper panel) ; Survival according to Balthazar grade 
C (n=7), D (n=41), or E (n=53), respectively (lower panel) ; Both as assessed at entry into the 
study,jor both treatment groups combined. Severe acute pancreatitis was defined according to 
Imrie score ~ 3 points andlor CT findings according to Balthazar's degree of disease severity 
grade D or E. 
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Table 3. Multivmiate analysis of mortality in relation to treatment, Imrie score, and Balthazar 
grade 
Factor 
Treatment 
control 
SD 
Imrie score 
Balthazar grade 
CID 
E 
I' 
0.3 
3.7' 
I' 
1.8 
Odds-ratio 
(0.3) 
(3.9) 
0.048 
<0.001 
0.354 
p-Value 
(0.049) 
«0.001) 
"" : reference category. + : relative to patients who have an Imrie score of I point less. Data given 
are odds-ratios for mortality. (Odds-ratios> 1 indicate an increased mortality; < 1 indicate a 
decreased mortality.) Data between parentheses denote results when only treatment and Imrie 
score are analysed regm'ding mortality. 
SD regimen: complications and failure of SD 
There were no noticeable allergies in the SO regimen, and none of the deaths in 
the SO group were attributable to the SO regimen. SO was started within 24 hours 
from randomization in all patients in the SO group, except one patient (day 4). The 
average length of SO treatment was 19 days. Oral paste and rectal enemas were 
well tolerated. Gram-negative colonization of the digestive tract was successfully 
prevented or reversed in 46 of 50 patients (92%) of the SO group. However, 
failure of SO to prevent gram negative colonization of the digestive tract with 
subsequent infection of pancreatic necrosis with the same gram negative bacteria 
was seen in 4 of 50 patients (8%). Three of these patients died after 9, 37, and 40 
days due to infection with Pseudomollas aemgillosa (2 pts.) and Klebsiella (1 pt.). 
Escherichia coli «1 +) was isolated only once from pancreatic necrosis in one of 
these patients at the end of the first week because of initial persistance of intestinal 
E. coli. Transient gram-negative pancreatic infection during SO treatment was 
seen in one patient-i.e., PseudoJlolllas aemgiJlosa «3 days) followed by Serratia 
lIIarescesceJlS «18 days)-who was later discharged after 106 days. 
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Table 4. Bacteriologic Analysis of Infected (peri)Pancreatic Necrosis. Presence of Micro-
organisms' 
Species 
Gram negative aerobic 
Acinetobacter spp. 
Citrobacter spp. 
Escherichia coU 
E1Iferobacter spp. 
Klebsiella spp. 
Pseudomonas spp. 
Proteus spp. 
Morganella spp. 
Serratia maresc. 
Alcaligenes spp. 
Gram positive aerobic 
Staphylococci spp. 
Staph. Gureus 
Staph. epidermidis 
Streptococci 
Enterococci 
Yeasts 
Candida a/bieans 
SD group (11=9) 
I 
3 
4 
9 
2 
7 
2 
Control group (n=20) 
3 
3 
12 
5 
5 
10 
2 
4 
I 
4 
12 
12 
10 
*: micro-organisms may occur in combinations in each separate patient 
Surgery and surgery-related morbidity 
In the control group, an average of 3.1 laparotomies was pelformed per patient in 
contrast to only 0.9 in the SO group (p<0.05; Table 5). A laparostomy, whenever 
repeated necrosectomy was foreseen, was created in 50% of the patients in both 
groups. In the control group surgical complications were seen in nine patients 
compared with four patients of the SO group, who had undergone surgery less 
frequently (p=0.50, N.S.). 
Median hospital stay in patients who survived was 30 days (range 10-106) in the 
SO group compared with 32 days (range 6-241) in the control group (p=0.65, 
N.S.). 
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Table 5, Surgery and Surgical Morbidity 
SD group 
(11 = 50) 
Control group 
(11 = 52) 
Laparotomy 
Laparotomies/pt (range) 
Patients with surgery-related 
complications 
Complications+: 
16 
0.9' 
4 
(32%) 
(0-17) 
(8%) 
24 
3.1' 
9 
Small bowel resections a 5 
Large bowel resections I 7 
Enteric fistulas 2 6 
Pancreatic fistulas 2 2 
Splenectomy 0 3 
(46%) 
(0-29) 
(17%) 
*' : p < 0.05 ; + : complications may occur in combinations in each separate patient. 
L1parostomies were created in 8 out of 16 patients in the SD group and in 12 out of 24 patients 
in the control group. Data given are numbers of patients (percentages) or mean (range). 
DISCUSSION 
TIle division of severe acute pancreatitis into an early vasoactive toxic phase and 
a late phase dominated by septic complications is widely accepted'·J'··o. Systemic 
complications during the initial phase of circulatory depression, such as 
myocardial depression, acute renal and respiratory failure, are thought to be 
mediated by activated pancreatic enzymes and other vasoactive and toxic agents 
released from the pancreas and the peritoneal exudateJ8.41.42. Intensive treatment 
has improved the prognosis with regard to these complications, which previously 
were the major cause of death during the early phase of severe acute 
pancreatitis38.4J.44 . 
Secondary infection of pancreatic necrosis currently is the most lethal 
complication of severe acute pancreatitis, particularly during the later stages of the 
disease2.9.IJ.I7,20,J8.4'. Gram-negative (facultative) aerobic bacteria, originating from 
the digestive tract, are predominantly isolated from infected pancreatic 
necrosis'·14.19.2J.26. Recently, Medich et al. reported that acute pancreatitis in rats 
promotes translocation of gastrointestinal organisms to the inflamed pancreas and 
peripancreatic region". Widdison et al. reported striking results from a feline 
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model, suggesting gut-derived pancreatic infection by showing that labeled 
intestinal E. coli were not recovered from the site of acute necrotizing pancreatitis 
when the colon was enclosed in an impermeable bag that prohibited 
translocation" . 
Until now, the beneficial effect of prophylactic antibiotics in acute pancreatitis 
has been debated!2.!'.". Recently, Pederzoli et al. reported that prophylactic 
treatment with intravenous imipenem significantly reduced the incidence of 
infected necrosis (12.2%) as compared with placebo (30.3%). However, no 
significant reduction in mortality could be demonstrated46 • If increased bacterial 
translocation from the digestive tract is the mechanism leading to pancreatic 
infection, selective decontamination should, in theory, be nseful in preventing 
pancreatic infection". McClelland et al. reported a significant reduction in clinical 
signs of sepsis in patients with acute pancreatitis and acute respiratOlY failure who 
were treated with SD3!. No significant reduction in mortality, however, was 
demonstrated from this retrospective analysis comprising only six SD patients in 
a 3-year period, who were compared with nine historic control patients from an 
earlier 3-year period. Reduction of mortality in ICU patients treated with adjuvant 
SD is still a matter of debate"-34, and randomized controlled clinical trials of 
selective decontamination in the treatment of patients with severe acute 
pancreatitis are not available. In the prospective clinical trials reported to date, 
only a few patients had severe acute pancreatitis or developed pancreatic infection. 
In the present study, SD significantly (p=0.003) reduced the incidence of gram-
negative pancreatic infection. Consequently, a significant reduction in the number 
of laparotomies having fewer surgely-related complications occurred in patients 
treated with SD. 
Because infection of originally sterile pancreatic necrosis is a secondary 
phenomenon, effective antibiotic prophylaxis may result mainly in reduction of 
late mortality. Early mortality, rather dOlninated by effects of vasoactive and toxic 
agents released from the pancreas and peritoneal exudate than by septic 
complications, may consequently be less reduced by antibiotics38-42. Tills may 
explain why SD, reducing total mortality, did not affect early mortality (within 2 
weeks) as appeared on further analysis (SD: 16%; 8/50 patients; control: 15%; 
8/52 patients)(p=O.71). Late mortality, on the other hand, was significantly 
reduced by SD (SD: 7%; 3/42 patients; control: 23%; 10/44 patients). In both 
groups all gram-negative pancreatic infections, if present, were preceded by 
colonization of the digestive tract with the same gram-negative bacteria. If 
pancreatic necrosis was infected despite successful SD, only gram-positive aerobic 
bacteria were isolated as has also been noted by others". If SD fails, however, 
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mortality increases sharply, which has has been recognized earlier in surgical 
intensive care patients". 
Severity scoring of acute pancreatitis immediately after admission has 
previously been strongly advocated to identify patients at risk"·36.49.5I. It also 
enables clinicians to compare treatment results more accurately. Scoring systems 
should be accurate but easy to use. TIle Imrie score proved to be very valuable in 
identifying patients with acute pancreatitis with increased tisk of death. Computed 
tomography findings, according to Balthazar's degree of disease severity, were less 
accurate in predicting prognosis. Total mortality of patients who were found to 
have severe acute pancreatitis according CT findings alone (Balthazar grade D or 
E, but Imrie score <3) was less than 5% in each group. These data suggest that the 
use of SD in such patients may not result in additional benefit and is cost-
inducing. 
CONCLUSIONS 
We conclude that SD is especially indicated for patients with severe acute 
pancreatitis with an Innie score ~3, regardless of the CT findings36 on admission. 
Treated as such, in this study total mortality was reduced from 55% (17/31 
patients) to 31 % (11/35 patients) with a 95% confidence interval for the difference 
in mortality ranging from 0% to 48%. 
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ABSTRACT 
Results of a previous randomized multicenter trial involving 102 patients with 
severe acute pancreatitis treated with or without adjuvant selective 
decontamination (SD) were analyzed additionally with regard to the bacteriologic 
status of (peri)pancreatic necrosis. 
The incidence of gram-negative pancreatic infection was significantly reduced 
in patients treated with SD (p=0.004). Once such an infection develops, mortality 
increases 15-fold (p<O.OOI) in compmison with that for patients with sterile 
necrosis. Among patients in whom only gram-positive infection of (peri)pancreatic 
necrosis was found, there was no significant increase in mortality. These results 
were similar in both treatment groups. In addition, the hospital stay was 
significantly longer in cases of gram-negative infected necrosis. The incidence of 
gram-positive infected necrosis in patients treated with SD did not increase. 
Gram-negative pancreatic infection can be prevented with adjuvant SD, thereby 
reducing mortality among patients with severe acute pancreatitis. 
INTRODUCTION 
As infectious complications have become the leading cause of mortality and 
morbidity in cases of acute necrotizing pancreatitis, patients in whom devitalized 
pancreatic and pedpancreatic tissues remain sterile have to be distinguished from 
others in whom secondary infection of (peri)pancreatic necrosis develops (i.e. 
sterile vs. infected necrosis). 
Sterile (peri)pancreatic necrosis, especially in the absence of systemic 
complications, has a favorable prognosis, with a repOited mortality rate of zero to 
II %1"'. Mortality, which increases sharply with increasing Ranson or Imrie score 
on admission, is related to systemic complications resulting in multiple organ 
failure, occurring most frequently during the first two weeks of illness'·lO. 
Infected necrosis on the other hand, occurs later during the course of the disease, 
often proves fatal, and is generally agreed to represent an absolute indication for 
surgery in an effort to reduce mortality'·"·'4. 
Cultures in cases of infected necrosis yield most frequently a polymicrobial 
flora, with a preponderance of gram-negative aerobic bacteda in 50%-70% of 
cultures, suggesting an enteric origin'·'·I2·I5·I9. Gram-positive aerobes (mainly 
enterococci and staphylococci) are isolated in only 5%-20% of cultures'·'·I2·IS.19. 
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Patients with severe acute pancreatitis in whom infected necrosis exists are usually 
dealt with as one group, irrespective of the specific flora cultured. However, 
because of varying intrinsic pathogenic potential, the prognosis of patients with 
infected (peri)pancreatic necrosis may differ according to the bacteria cultured. In 
accordance with results of bacteriological analyses of infected (peri)pancreatic 
necrosis, two major groups of patients can be distinguished: those with gram-
positive infected necrosis and those with gram-negative infected necrosis. This 
distinction between patients with infected (peri)pancreatic necrosis has not been 
studied prospectively to date. 
In a recent controlled clinical trial, selective decontamination (SO) was shown 
to effectively reduce m01tality among patients with objective signs of severe acute 
pancreatitis'. However, SO does not prevent gram-positive infection. Subsequent 
intestinal overgrowth with Enterococcus species, resulting in an increase in gram-
positive infections, has been suggested to be a limitation of 5020. 
An additional analysis of the results of this prospective, controlled clinical study 
was performed to evaluate for both treatment groups (i.e., the SO group and 
control group) a possible difference concerning mortality between (I) patients 
with either gram-positive infected necrosis or gram-negative (peri)pancreatic 
infection during the course of the disease and (2) patients in whom 
(peri)pancreatic necrosis remained sterile. 
PATIENTS AND METHODS 
Patients 
Between Apri122, 1990 and April 19, 1993, 102 patients with objective signs of 
severe acute pancreatitis were admitted to 16 pmticipating hospitals. The diagnosis 
of acute pancreatitis had been established on the basis of clinical examination and 
elevated plasma levels of serum amylase (> 1 ,000 IUIL; normal range, 0-300 lUlL 
(Phadebas)), or at diagnostic laparotomy (10 patients). All patients had severe 
acute pancreatitis, according to a multiple laboratory criteria score (Imrie score:>3) 
andlor grade 0 or E (Balthazar grades) determined by contrast-enhanced CT7•21 • 
Bacteriologically proven infected necrosis at the time of randomization was 
defined as an exclusion criterion. 
The patients were randomly assigned to receive standard treatment (control 
group: n=52) or the same treatment plus selective decontamination (SO group: 
n=50). A 24-hour randomization service was available to randomize patients, with 
39 
Chapter 3 
stratification per center. Informed consent was obtained from the patient or 
relatives by the attending clinician. 
The SD regimen consisted of oral administration of colistin sulfate (200 mg), 
amphotericin (500 mg) and norfloxacin (NoroxinR; 50 mg) evety 6 hours. A sticky 
paste containing 2% of the three SD dl1lgs was smeared along the upper and lower 
gums every 6 hours and at the tracheostomy, if present. The aforementioned daily 
dose also was given in a rectal enema every day. A short-term systemic 
prophylaxis of cefotaxime sodium (ClaforanR; 500mg) was given every 8 hours 
until gram-negative bacteria were eliminated from the oral cavity and rectum 
(average, 7.4 days). SD was discontinued as soon as the risk of acquiling a new 
infection was absent, i.e., the patient was extubated receiving no supplementaty 
oxygen therapy or infusions, on regular oral diet, and ambulatory on the ward. A 
more elaborate outline has been reported in chapter 2. 
Microbiology 
An ultrasonography or CT-guided fine-needle aspiration (FNA) with subsequent 
culture was performed if there was clinical suspicion of infected (peri)pancreatic 
necrosis ll • Clinical suspicion of (peri)pancreatic infection was based on the 
occurrence of fever and leukocytosis (usually lasting at least 2-3 days, during 
which other sources of infection were excluded), associated with CT-findings 
demonstrating (peri)pancreatic necrosis. 
The microbial flora of the infected pancreas was carefully monitored. Culture 
specimens of pancreatic and peripancreatic devitalized tissues (i.e., necrosis) were 
obtained at every laparotomy and from drainage. They were sent dil'ectly to the 
laboratory and cultured semiquantitatively. If fever (~39°C) was present, blood 
cultures were performed. Identifications were made following routine 
microbiological procedures. 
Pancreatic necrosis, peripancreatic devitalized tissues and fluid collections were 
considered sterile in those patients with a nonseptic course and in those with 
negative cultures. 
Snrgery 
Besides severe intraabdominal hemorrhage or presence of entedc fistulas, reasons 
for surgery included (I) aspirate cultures that demonstrated development of 
infected necrosis and (2) rapid detedoration of the patient's condition toward 
multiple-organ failure that was resistant to exhaustive intensive treatment (SD 
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group, 16 patients; controls 24). Results of surveillance cultures of the digestive 
tract were not taken into account in the decision to perform a reintervention. The 
decision to perform either percutaneous drainage or relaparotomy was based on 
ultrasonographic and CT findings as well as findings from the previous 
laparotomy. 
Access to the pancreas was obtained through a median or (preferably) transverse 
laparotomy. If repeated laparotomies were foreseen, a laparostomy (i.e., ventral 
open packing of the abdominal cavity) was created, ensuring a rapid and easy 
access to the upper abdominal cavity". Removal of necrotic tissue was mainly 
performed by means of finger or clamp fraction (i.e., necrosectomy). Infected 
necrosis is mostly solid, in contrast with a pancreatic abcess, which represents a 
localized collection of fluid, often encapsulated, that occurs after the pancreatitis 
has subsided. 
Statistical Analysis 
Percentages and continuous data were compared between groups by means of 
Fisher's exact test and Mann-Whitney's test, respectively. Cumulative percentages 
of patients developing gram-negative or gram-positive infected necrosis, taking 
account of the length of survival, were assessed by the actuarial Kaplan-Meier 
method and log-rank-test. Cox regression was used to evaluate various factors 
simultaneously regarding mortality". This method was also used to assess the 
relation between the OCClU1'enCe of pancreatic infections (only gram-negative, only 
gram-positive or mixed gram-negative/gram-positive) and mortality23. P-values 
given are two-sided, and p=0.05 was considered the limit of significance. 
RESULTS 
Of 102 patients with objective signs of severe acute pancreatitis (Imrie score;>3 
andlor Balthazar CT score grade of D or E), 50 patients were assigned to the SD 
group and 52 to the control group. The groups were well matched with regard to 
Imrie score (mean for both: 3.2) and Balthazar grade as is demonstrated in 
chapter 2. 
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Microbiology 
Twenty-nine of 102 patients (28%) developed infected (peri)pancreatic necrosis. 
Pseudomonas aeruginosa (13 patients), Escherichia coli (13), Staphylococcus 
epidermidis (21) and enterococci (19) were most frequently isolated; anaerobes (3) 
were found to play only a minor role and were not further analyzed. 
Infected necrosis occurred in 9 of 50 patients (18%) of the SD group in 
comparison with 20 of 52 patients (37%) of the control group (p=0.03), because 
of a significant reduction of gram-negative infected necrosis (SD group, 4/50 
(8%); controls, 17/52 (33%)). Three patients who developed infected necrosis had 
not undergone surgery. Infected necrosis was demonstrated at autopsy (two 
patients) or by percutaneous drainage ( one). 
Figure 1 shows the increasing percentage of patients over tinle who developed 
gram-negative pancreatic infection. The incidence of gram-positive infection of 
(peri)pancreatic necrosis did not significantly differ between treatment groups 
(SD, 9/50 (18%); controls, 16/52 (31%)) (Figure 1). 
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Figure 1. Cumulative percentage over time of patients \vith infection due to gram-negative 
bacteria (left panel) and with gram-positive infection of (peri)pancreatlc necrosis (right panel) 
according to treatment group. In parentheses are numbers of patients at risk. ---- ::::: control group 
(n=52); -- = Selective Decontamination group (n=50 pts.) 
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The Imrie score at enrollment in the study appeared to cOll'elate very strongly with 
the incidence of gram-negative (peri)pancreatic necrosis over time, especially in 
the control group (p<O.OOI) (Figure 2). The Balthazar grade at enrollment in the 
study also correlated with the incidence of gram-negative pancreatic infection, 
although tltis cOll'elation was less pronounced (Grade CID, 6/48 (12%); Grade E, 
14/53 (26%)) (with adjustment for treatment group, p=O.03). 
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Figure 2. Cumulative percentage over time of patients with gram-negative infection of 
(peri)pancreatic necrosis in the control group (left panel) and SD group (right panel), according 
to Imrie score (T, 0-2; II, 3-4; III, >4) at enrollment in the study. Control group scores: I, 21 
patients; IT, 19; Ill, 12; Ptrend <0.001. SD group scores: I, 15 patients; IT, 22; Ill, 13; Ptrend=0.08. 
Fourty FNAs were perfOlmed in 25 patients (range, 1-4 per patient). Twenty-one 
of these FNAs (17 patients) were done without treatment with intravenous 
antibiotics at the time of aspiration. Only 4 of these aspirations (19%) showed 
presence of bacteria (E. coli I, S. epidermidis, 3). Nineteen FNAs (16 patients) 
were done during simultaneous treatment with intravenous antibiotics. Eight of 
these (42%) showed infection of (peri)pancreatic necrosis (Enterobacter species, 
1; Klebsiella species, I; S. epidenllidis, 4; enterococci, 4; Staphylococcus aureus, 
I). Some aspirates contained more than one type ofbactetia. 
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Mortality 
Mortality is significantly reduced among patients treated with adjuvant SD'. 
Among patients who survived (n=73), the percentage of cases in whom infected 
necrosis had occurred was 19% (14 patients), which is significantly (p=0.002) 
lower than the S2% (IS) of non-survivors (n=29) (Table I). 
To evaluate the impact on mortality of infected (peri)pancreatic necrosis 
developing during treatment, patients were classified each day according to 
whether pancreatic necrosis was still sterile, or whether only a gram-positive, only 
a gram-negative or a mixed gram-negative/gram-positive pancreatic infection had 
occurred. All patients started in the sterile condition in accordance with the 
enrollment criteria. With the use of Cox regression for both groups, it emerged that 
in compadson with patients with sterile necrosis, those who acquired only a gram-
positive pancreatic infection had a 1.6-fold increased death rate (p=0.S2) . Patients 
who developed only a gram-negative pancreatic infection had a 14.4-fold 
increased death rate (p<O.OO 1) in comparison with the rate for those with sterile 
necrosis. A similar increased mOltality of IS.8-fold (p< 0.001) was found for those 
with mixed gram-negative/gram-positive infected necrosis. 
Table 1. Bacteriologic classification of (peri)pancreatic necrosis during the course of the disease. 
Analysis with regard to survivors and nOll~survivors. 
Classification 
Sterile 
Only gram-positive 
Only gram-negative 
Mixed gram-positive/negative 
59 
6 
8 
No. (%) of patients 
Survivors 
(n=73) 
(81 %) 
(8 %) 
(-) 
(II %) 
14 
2 
4 
9 
Non-survivors 
(n=29) 
(48 %) 
(7 %) 
(14 %) 
(31 %) 
Data given are numbers of patients with percentages between parentheses. The percentage of 
patients with infected (peri)pancreatic necrosis among non-survivors (15129; 52%) is significant-
ly higher as compared to survivors (14173; 19%) : p=O.002. 
44 
D{(ferellfial Prognosis Infected Pancreatic Necrosis 
Table 2. Results of multivaIiate analysis of mortality in relation to development of infection of 
(peri)pancreatic necrosis during treatment, baseline Imrie-score, baseline Balthazar grade and 
randomized treatment. All patients start in the sterile category in accordance with the entry 
criteria. 
Factor No. of death' Relative death Significance';> 95% Confidence 
Infected pancreatic 
necrosis 
Stelile 14/5,209 
OnlyG+ 2/615 
OnlyG- 4/103 
Mixed G+/G- 91508 
Imrie score 
0-2 1/36 
3-4 9/41 
5-7 19/25 
Balthazar grade 
CID 9/48 
E 20153 
Treatment group 
Controls 18/52 
SD 11/50 
rate 
I' 
1.2 
8.0' 
7.0' 
I' (I) 
704 (10.6) 
31.2 (56.8) 
I' (I) 
0.9 (1.3) 
I' (I) 
0.8 (004) 
.86 
.001 
.002 
.06 
.001 
.76 
.56 
limits of relative 
death rate 
0.2,5.5 
204,27.1 
2.1,24.5 
( ... ) 
(.03) 0.9,60.3 
(.001) 3.9, >100 
( ... ) 
(.38) 0.3,2.3 
( ... ) 
(.03) 0.3, 1.8 
(G+: graIn-positive; G-: gram-negative; SD: selective decontamination). Parentheses around data 
denote results obtained without allowance for the factor infections (infectious status). Upon 
enrollment, CT (Balthazar grade) was not available for one patient as explained in chapter 2. 
* number denotes the number of patient-days (up to day 80, i.e. the day number of the last death) 
after the first occurrence of the infection specified, or the number of patients for Imrie score, 
Balthazar grade or treatment. 
<) comparison with reference category 
* reference category 
§ not significantly different from each other, but both significantly greater in com.parison with 
"Only G+" category value 
Table 2 shows results of multivariate analysis of the relationship between 
mortality and the type of pancreatic infection, taking into account the Imrie score, 
Balthazar grade, and randomized treatment. TIlis analysis demonstrates that 
development of a gram-negative infection of (peri)pancreatic necrosis during the 
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course of the disease is an important and ominous sign, while there was no 
significant increase in mortality due to gram-positive pancreatic infection. With 
these infections taken into account, there is still an increased death rate of patients 
with a higher Imrie multifactorial initial assessment. No additional prognostic 
value was found for the Balthazar grade. The data between parentheses (Table 2) 
also show that SD decreases mortality when analyzed without consideration of 
infectious status. 
There was no mOltality difference between treatment groups for patients without 
gram-negative infected necrosis (i.e. sterile or only gram-positive) as demonstrated 
in Figure 3 (left panel). After the OCCU11'ence of a gram-negative pancreatic 
infection mortality was high (13121; 62%). As shown in Figure 3 (right panel) 
survival in these patients did not significantly differ between treatment groups. 
However a gram-negative pancreatic infection occurred in only four patients in the 
SD group. 
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Figure 3. Left. survival from the time of enrollment in the study. counting only deaths of patients 
with sterile or only gram-positive infected (peri)pancreatic necrosis, according to treatment 
group. Tick marks (X) denote deaths after gram-negative infection of (peri)pancreatic necrosis. 
Right, survival after the occurrence of gram-negative infection of (peri)pancreatic necrosis, 
according to treatment group. (C=control group~ SD=selective decontamination group) 
46 
D{{ferellfial Prognosis Infected Pancreatic Necrosis 
Hospital stay 
The average hospital stay of survivors with gram-negative infected 
(ped)pancreatic necrosis (8 patients) was 135 days (range, 56-241 days), which is 
significantly higher than the mean values of 55 days (range, 26-82 days) (p=O.OI) 
and 30 days (range, 10-71 days) (p<O.OOI) for survivors with only gram-positive 
(6 patients) or sterile necrosis (59), respectively. Although smaller, the difference 
between hospital stay of survivors with only gram-positive infected and sterile 
necrosis is also significant (p=0.004). These results were similar in both treatment 
groups (SD group and controls). 
DISCUSSION 
This study demonstrates that mOitality increases dramatically once gram-negative 
infection of (peri)pancreatic necrosis occurs in patients with severe acute 
pancreatitis. However if (peri)pancreatic necrosis becomes infected with only 
gram-positive aerobic bacteria, mortality is not significantly increased and is 
comparable with that among patients in whom pancreatic necrosis remains sterile 
throughout the course of the disease. This is probably because S. epidel'lI1idis or 
enterococci, most frequently isolated in cases of infected necrosis due to a solitary 
gram-positive organism, are less pathogenic in these patients. 
The overall incidence of secondmy infection of (ped)pancreatic necrosis is 28%. 
In the control group infected necrosis occUlTed at a rate of 38%, which has also 
been described by others!,!5.'". In patients treated with SD, the overall incidence 
of infected necrosis (18%) was significantly reduced because of a marked 
reduction of gram-negative infected necrosis (only 8%, vs. 33% in the control 
group). The occurrence of a gram-negative infection of (ped)pancreatic necrosis 
is an ominous sign. Mortality among these patients increases significantly, 
irrespective of coexistence of a gram-positive infection, as shown in this study. 
Mortality with regm'd to the bactedologic status of (peri)pancreatic necrosis was 
comparable for the SD group and the control group, i.e., once gram-negative 
infection of (peri)pancreatic necrosis occurred, mortality increased considerably 
in both treatment groups. However, mortality in the treatment group was 
significantly reduced among patients treated with adjuvant SD (Table 2), a finding 
that was also published previously5. 
Consequently, SD reduces mortality among patients with severe acute 
pancreatitis because of a significant reduction in the development of gram-
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negative infection of (peri)pancreatic necrosis. This is accomplished by reduction 
of gram-negative intestinal colonization, leading to reduced gram-negative 
bacterial translocation into the (peri)pancreatic necrosis. However, SO is not 
useful for patients in whom gram-negative pancreatic infection ah'eady exists or 
develops during SO administration, as is demonstrated in this study. 
It has been suggested that overgrowth and translocation of gram-positive 
bacteria, i.e., enterococci or staphylococci, may be a drawback of SD20,,,. Our 
results do not snpport this hypothesis. Neither intestinal overgrowth nor increased 
incidence of gram-positive infected necrosis has been found in our study. Deaths 
due to unexplained gram-positive sepsis along with positive blood cultures (two 
patients) and otherwise-documented sterile necrosis at time of death were equally 
divided among the SO group and the controls. However, these possible hazards 
demand shict indications and careful bacteriologic surveillance, as is the case for 
any kind of antibiotic regimen. 
CONCLUSIONS 
The development of gram-negative infection of devitalized tissues in and around 
the pancreas is, apart from the Imrie score, the most important parameter 
determining outcome. Gram-negative pancreatic infection can be minimized with 
adjuvant SO, thereby reducing mortality among patients with severe acute 
pancreatitis. 
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ABSTRACT 
Secondary gram-negative pancreatic infections are the major cause of morbidity 
and mortality in patients with severe acute pancreatitis. Several experimental 
studies have indicated that the microbial flora causing these infections is gut-
originated, however clinical results of gram-negative intestinal colonization in 
patients with pancreatic infections have not been reported to date. 
A prospective analysis of 2159 semi-quantitive cultures from the oropharynx, 
rectum and pancreatic tissues taken from 90 patients revealed that all gram-
negative pancreatic infections were preceded by intestinal colonization with the 
same micro-organisms. The risk of developing a pancreatic infection following 
gram-negative intestinal colonization (15142 pts.) was significantly increased as 
compared to patients without gram-negative colonization (0/18 pts.)(p<O.OOI) or 
to patients in whom E. coli was the only intestinal micro-organism cultured 
(0/30 pts.) (p<O.OOI). The occurrence of intestinal E. coli did not increase the risk 
of pancreatic infection. Gram-negative colonization of the rectum and oropharynx 
significantly correlated with later development ofpancratic infection: relative risks 
73.7 (p<O.OOl) and 13.6 (p<O.OOl) respectively. However, when both areas were 
evaluated simultaneously, the rectum was more significant (p<O.OO I). The severity 
of intestinal colonization until the moment of pancreatic infection showed an 
increase in time in all 15 patients. In 11 of 15 patients (73%) these infections 
occurred within 1 week following the first isolation from the digestive tract. Gram-
negative intestinal colonization was associated with a 3.7 fold increased mortality 
risk (p=0.004). 
Gram-negative intestinal colonization, E. coli excepted, is an early prognostic 
parameter in patients in whom pancreatic infection has not yet occurred and 
represents a significantly increased risk of pancreatic infections and mortality. 
INTRODUCTION 
Since advances in critical care have greatly reduced the incidence of death caused 
by the early cardiopulmonary sequelae of severe acute pancreatitis, secondary 
infections of (peri)pancreatic necrosis have emerged as the leading cause of 
mortality and morbidity in these patients 1.5. 
The microbiology of pancreatic infections in patients with severe acute 
pancreatitis, which reveals mainly aerobic gram-negative bacteria, provides 
indirect evidence that these pathogens originate from the digestive trace·5-1O• 
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Colonization of the digestive tract is thought to be the initial step of endogenous 
infection of other major organ systems (e.g. pancreas)ll.l'. Several experimental 
studies have demonstrated that acute pancreatitis promotes bacterial translocation, 
leading to infection of the inflamed pancreas and surrounding tissues 13-20 • 
The development of gram-negative infection of (peri)pancreatic necrosis 
significantly increases the risk of mOltality in patients with severe acute 
pancreatitis'l. As attention has rightly turned to prevention of pancreatic infection, 
early identification of patients who are at risk of developing a gram-negative 
pancreatic infection during the course of the disease is crucial to improving the 
outcome of severe acute pancreatitis. To date, prognostic scores on admission, 
using laboratOly parameters (e.g. Imrie score) or contrast-enhanced CT findings 
(e.g. Balthazar grades) are the only clinical available tools for early identification 
of patients who are at risk of future pancreatic infection2l-23 , and fine needle 
aspiration of pancreatic necrosis with subsequent gram-staining and culture of the 
aspirate is the only means of the early detection of patients in whom infection has 
ab'eady developed'4. Early identification, using microbiological criteria, of patients 
who are at risk of developing a life-threatening gram-negative pancreatic infection 
during treatment has not been published so far. As several experimental studies 
have already indicated that the gut is the principal source of infection, analysis of 
the intestinal flora of patients with severe acute pancreatitis may reveal valuable 
prognostic data. However, clinical investigations concerning gram-negative 
intestinal colonization which may precede pancreatic infection in patients with 
severe acute pancreatitis have not been reported to date. 
In this study the results of systematic semi-quantitive cultures of several body 
areas taken from patients with severe acute pancreatitis, during a controlled 
multicenter trial of adjuvant selective decontamination (SD), were analyzed to 
address the following questions: 1) Does gram-negative (re)-colonization of the 
gut lead to an increased risk of gram-negative pancreatic infection and is this event 
time-related? 2) Does the difference in the quantity and quality of micro-organisms 
colonizing the digestive tract influence the morbidity and mortality of severe acute 
pancreatitis? 
PATIENTS AND METHODS 
The microbial flora of patients with objective signs of severe acute pancreatitis 
was carefully monitored during a controlled clinical trial of adjuvant selective 
decontamination (control group n=52 patients, selective decontamination group 
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n=50 patients). All patients suffered from severe acute pancreatitis according to 
a multiple laboratory criteria score (Inn'ie score;,3) andlor grade D or E disease 
severity (Balthazar grades) using contrast-enhanced computerized tomography 
(CE-CT)"·26. An elaborate outline has been reported previously". The study was 
conducted according to the principles established in Helsinki. 
Microbiology 
Surveillance cultures from the oropharynx and rectum were taken on admission 
and repeated twice weekly. If fever (;,39°C) was present, blood cultl\1'es were 
taken 
An ultrasonographic- or CT-guided fine needle aspiration with subsequent 
cultl\1'e was pelfol'lned if there was clinical suspicion of infected pancreatic 
necrosis". Clinical suspicion of pancreatic infection was based on fever and 
leucocytosis (usually lasting at least 2-3 days dl\1'ing which time other sources of 
infection were excluded) associated with CT-findings demonstrating 
(peri)pancreatic necrosis. Sl\1'veillance cultures of the (peri)pancreatic devitalized 
tissues (i.e. necrosis) were obtained at every re1aparotomy and from drainage. 
They were sent directly to the laboratOlY and cultured semi-quantitatively 
(1+,2+,3+,4+)28. Samples from the oropharynx and rectum were taken with a 
sterile cotton-tipped swab and cultl\1'ed semi-quantitatively. 
Identification was performed following routine microbiological procedures. 
Pancreatic necrosis, peripancreatic devitalized tissues or fluid collections were 
considered sterile in those patients pl\1'suing a non septic course and in patients 
with negative cultl\1'es. 
Analysis of gram-negative intestinal colonization 
For each patient, a time-based qualitative microbiological profile, including the 
date of first occurrence as well as the dl\1'ation of colonization of specific gram-
negative micro-organisms was recorded (orophmynx, rectum and pancreas). For 
all sites, a tinle-based semi-quantitative microbiological profile was created for 
each patient in order to analyse the severity of gram-negative intestinal 
colonization. The maximum semi-quantitative growth was recorded and used in 
this analysis. Another similar semi-quantitative profile was made excluding 
E. coli. The (resident) E. coli is considered separately in order to facilitate the 
determination of nosocomial gram-negative intestinal colonization without 
interference of the host's own E. COlP9. For every patient, monomicrobial, 
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polymicrobial or absence of gram-negative intestinal colonization was also 
recorded during the course of the disease. 
Patients in whom insufficient surveillance cultures had been taken to pelform 
a reliable analysis, i.e. more than one week without surveillance cultures, were 
exluded from this analysis. 
Follow up was continued until either death or the risk of development of a 
pancreatic infection was considered negligible-i.e. the patient was extubated and 
without supplementary oxygen therapy or infusions, on a regular oral diet, and 
mobilized on the ward. Selective decontamination was also discontinued at that 
same time. 
Statistical Analysis 
The relation between the OCCUll'ence of gram-negative intestinal colonization and 
the risk of developing a gram-negative pancreatic infection with time was 
investigated using Cox regression with time-dependent variables30• The same 
technique was used to evaluate the relation between gram-negative intestinal 
colonization and mortality. The cumulative risk of gram-negative pancreatic 
infection after the first occurrence of gram-negative intestinal colonization was 
assessed using the actuarial Kaplan-Meier method. Two-sided p-values of 0.05 or 
less were considered statistically significant. 
RESULTS 
Of 102 patients who entered the study, 12 were excluded from this analysis 
because insufficient intestinal surveillance cultures had been taken. A total of 
2159 surveillance cultures (90 patients) were analyzed, including 430 cultures 
taken from devitalized (peri)pancreatic tissues (43 patients). Of the 90 patients, 15 
(17%) developed a gram-negative pancreatic infection during the course of the 
disease, 3 of 49 patients receiving adjuvant selective decontamination and 12 of 
41 control patients. 
Qualitative analysis of cultures from the digestive tract (i.e. orophalynx and 
rectum) and (peri)pancreatic tissues are presented in Table I. Only 6 of 62 patients 
(10%) in whom E.coli was found in the rectum (mostly present from the onset of 
the disease) developed pancreatic infection, which is remarkably low when 
compared to other gram-negative bacteria isolated from the lower intestine 
(Table 1). 
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Table 1. Qualitative Analysis of Gram-negative Intestinal Colonization, and Gral1Hlcgative 
Infected Pancreatic Necrosis. Incidence of Micro-organisms in 90 patientsa 
Escherichia coli 
Pseudomonas aerugillosa 
Klebsiella spp. 
Citrobactel' spp. 
Emerobacler spp. 
Morganella morganii 
Proteus spp. 
Serratia marescescens 
Acilletobacter spp. 
Oropharynx 
(no. patients) 
SD C 
3 8 
5 10 
1 2 
4 
4 
2 2 
1 
2 
Rechllll 
(no. patients) 
SD C 
31b 31b 
4 13 
3 10 
3 
5 
3 3 
6 
1 
3 
Pancreasa 
(no. patients) 
SD C 
6' 
2 9 
4 
2 
2 
2 
3 
SD: selective decontamination group, C: control group. Gram-negative intestinal colonization 
during treatment did not occur in 18 patients and in 30 of 64 patients E. coli was the only micro-
organism isolated from the digestive tract. a: micro-organisms may occur in combinations in 
each separate patient. (pseudomonas: 2, Pseudomonas + Acinetobaeter + Citrobaeter: 1, E.eali 
+ Aeinetobaeter: I, Pseudomonas + E.eoli + Morganella: 1, Pseudomonas + Klebsiella: 1, 
Pseudomonas + E.eoli + Klebsiella: 2, Pseudomonas + Enterobaeter: 1, Acinetobacter: 1, 
Pseudomonas + E.coli: 1, Pseudomonas + Citrobacter: 1, Klebsiella + Morganella: 1, 
Pseudomonas + E.coli + Enterobacter: 1, SelTatia: 1. b: incidence of granHlegative pancreatic 
infection following rectal isolation of E. coli is noticeably lower when compared to other gram-
negative micro-organisms. A mOllomicrobial pancreatic infection with E. coli did not occur. 
A monomicrobial pancreatic infection with E. coli did not occur. An analysis was 
therefore performed separating (resident) E. coli from other gram-negative 
bactetia, in order to facilitate the determination of intestinal colonization with 
gram-negative nosocomial micro-organisms, acquired during the hospital stay, and 
their relation to the development of pancreatic infection. 
Gram-negative intestinal colonization and pancreatic infection 
Of 48 patients in whom either intestinal colonization did not occur (n=18 patients) 
or in whom E. coli was the only micro-organism cultured during the course of the 
disease (n=30 patients), none developed a gram-negative pancreatic infection 
(Table 2). 
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However, of the 42 patients in whom gram-negative intestinal colinization 
occlmed (with or without additional E. coli) during the course of the disease, 15 
(36%) developed a gram-negative pancreatic infection. Using Cox regression 
analysis, the risk of developing a gram-negative pancreatic infection following 
intestinal colonization is significantly increased (p=O.003 and p<O.OOl) and 
intestinal E. coli is clinically unimportant (Table 2). The same significant 
differences were found when only patients were considered who did not receive 
SD (i.e. control group). As there were only 3 patients in the SD group with gram-
negative pancreatic infection, no separate reliable statistical evaluation of this 
group was possible. 
Table 2. Risk Analysis of Gram-negative Pancreatic Infection following Gram-negative 
Intestinal Colonization in 90 Patients with Severe Acute Pancreatitis 
Secondmy gram-negative pancreatic infection 
Present (%) Absent (%) p value 
(Cox regression) 
Intestinal colonization: 
Absence of gram-negative intestinal 
colonization 0 (0%) 18 (100%) # 
Only E. coli cultured 0 (0%) 30 (100%) n.s. 
Gram-negative micro-organisrn(s} 
without additional E. coli 4 (44%) 5 (56%) 0.003' 
Gram-negative m1cro-ol'ganism(s) with 
additional E. coli II (33%) 22 (67%) <0.001'" 
#: Reference category. a: Both P-values ::; 0.001 when compared to "only E. coli cultured". 
b: Occurrence of additional intestinal E. coli in patients with gram-negative intestinal 
colonization does not increase (p=0.91) the lisk to develop a gram-negative pancreatic infection 
as compared to patients in whom gram-negative intestinal colonization occurred without 
additional E. coli. 
The time lag between gram-negative intestinal colonization (E. coli excluded) and 
subsequent (peri)pancreatic infection is shown in Figure 1. In all patients gram-
negative pancreatic infection (n=15) was preceded by intestinal colonization with 
the same micro-organisms. The majority of these infections (11115, 73%) occurred 
within 1 week following the first isolation from the digestive tract. In four 
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patients, the same micro-organisms (Pseudomollas aerugillosa: 2, Ellterobacter 
spp.: 1, Citrobacterspp.: 1) were also isolated from blood samples taken because 
of fever during the interval between gram-negative intestinal colonization and the 
development of gram-negative pancreatic infection. In 9 (33%) of 27 patients 
without gram-negative pancreatic infection, gram-negative intestinal colonization 
(E. coli excluded) occurred with more than one species (polymicrobial) which is 
comparable to 6 (40%) of 15 patients with gram-negative pancreatic infection. 
Using Cox regression analysis, no significant relation was found between the 
occurrence of polymicrobial versus monomicrobial gram-negative intestinal 
colonization and the later development of gram-negative pancreatic infection. 
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Figul'e 1. Time lag between first day that gram-negative intestinal colonization (excl. E. coli) 
was demonstrated and establishment of secondary gram-negative pancreatic infection in 42 
patients. Tick marks (X) denote length of survival of patients dying without granHlegative 
pancreatic infection. 
Analysis of the rectum and oropharynx revealed that gram-negative pancreatic 
infection (n=15) was preceded by rectal colonization in five, oropharyngeal 
colonization in one and colonization of both areas in nine patients. In 27 patients 
without gram-negative pancreatic infection despite gram-negative intestinal 
colonization, rectal or oropharyngeal colonization was found in 13 and 6, 
respectively, and in both areas in 8 patients. Colonization of either area (i.e. 
rectum, orophmynx), when evaluated separately using Cox regression, 
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significantly con'elated with the later development of gram-negative pancreatic 
infection: the relative risks for rectum and oropharynx were 73.7 (p<O.OOI) and 
13.6 (p<O.OOI), respectively. These results, when only patients of the control 
group were analyzed, were 24.3 (p=0.003) and 6.8 (p=0.002), respectively. 
However, when both areas were evaluated simultaneously, colonization of the 
rectum was more important (p<O.OOl), while no additional predictive value was 
found for colonization of the oropharynx (p=0.34, n.s.). Figure 2 shows the degree 
of severity (semi-quantitative) of gram-negative rectal colonization until the 
moment of gram-negative pancreatic infection. An increase with time was found 
in all 15 cases except one (14/15). In the remaining patient gram-negative 
pancreatic infection was preceded by only oropharyngeal colonization, which also 
increased with time. Colonization persisted for more than one week in only 4 of 
21 (19%) patients with rectal colonization without gram-negative pancreatic 
infection. 
Number of days from onset of the disease untit the 
moment of {lram-ne{lative pancreatic fnfection (cut ofl)_ 
Figure 2. Severity (semiquantitative) of gra1l1~negative intestinal colonization with time in 15 
patients with gram-negative pancreatic infection. Rectal colonization is presented until the first 
day that gram~negative pancreatic infection was demonstrated. 
Gram-positive intestinal colonization and pancreatic infection 
No correlation was found between gram-positive intestinal colonization and the 
later development of gram-positive pancreatic infection. Gram-positive intestinal 
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colonization preceding gram-positive pancreatic infection was found in only 4 of 
21 (19%) patients (6 colonies isolated from 4 patients: Enterococci 4, Staphylo-
COCCliS epidermidis I and Streptococclis I). In the remaining 17 cases (81 %), 
intestinal gram-positive micro-organisms were either absent (n=9) or only found 
after gram-positive pancreatic infection had already developed (n=8). 
Gram-negative intestinal colonization and mortality 
Twenty-two patients (22/90 patients, 24%) died. Multiple organ failure with 
documented sterile (peri)pancreatic necrosis was the cause of death in nine 
patients. Nine patients died due to a gram-negative pancreatic infection. Two 
patients died due to solitary gram-positive pancreatic infection. Gram-positive 
sepsis of unknown odgin with documented sterile pancreatic necrosis was the 
cause of death in two other patients. 
Table 3. Risk Analysis of Mortality following Gram-negative Intestinal Colonization in 90 
Patients with Severe Acute Pancreatitis 
Non-survivor 
n (%) 
Intestinal colonization: 
Absence or only E. coli cultured 8 (17%) 
Gram-negative micro-organisrn(s) 
(with or without additional E. coli) 14 (33%) 
Survivor 
n (%) 
40 (83%) 
28 (67%) 
p value 
(Cox regression) 
0.004" 
MOliality risk is not influenced by intestinal E. coli. a: Gram-negative intestinal colonization is 
associated with a 3.7 fold increased mortality risk (p~0.004). 
Of 42 patients with gram-negative intestinal colonization, 14 (33%) died: 9 due 
to gram-negative pancreatic infection. Of the remaining 48 patients without gram-
negative intestinal colonization, 8 (17%) died. None of these eight patients died 
due to a gram-negative pancreatic infection. Table 3 shows that, when using Cox 
regression analysis, gram-negative intestinal colonization was associated with a 
3.7 fold (p=0.004) increased mortality dsk. This increase of mortality dsk was 7.4 
(p=0.02) in the control group, and 2.2 (p = 0.23) in the SD group. These relative 
risks for the two treatment groups did not significantly differ from each other 
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(p=0.24). Presence of intestinal E. coli, as the only micro-organism cultured or as 
an additional finding in patients colonized with other gram-negative flora, did not 
increase the mortality risk. 
DISCUSSION 
Several experimental studies have demonstrated that the intestinal tract is the 
origin of secondary pancreatic infection and have suggested possible routes of 
translocation13-20.31.32. Until now clinical studies have restJicted the microbiological 
analysis to cultures of (peri)pancreatic necrosis obtained by percutaneous 
aspiration or specimens taken during operation. Since predominantly gram-
negative bacteria have been found, reflecting the flora of the intestinal tract of 
lCU-patients, it has been suggested that these micro-organisms originate from the 
gut, from which they translocate during the course of the disease l •2.5-1O • 
This prospective analysis of the occurrence of gram-negative intestinal 
colonization during the course of the disease in patients with severe acute 
pancreatitis, provides direct clinical evidence that aerobic gram-negative 
pancreatic infections do originate from the gut. 
Besides anaerobes and enterococci, the normal colonic flora frequently consists 
of Enterobacteriaceae, predominantly E. coli. The colonization rate of E. coli 
remained the same during hospital stay as has also been reported by other 
investigators". However, other gram-negative micro-organisms (e.g. 
Pseudomonas spp., Acinetobacter spp.), referred to as nosocomial micro-
organisms, are acquired during hospitalization and colonize the digestive tract of 
more than 80% of rCU-patients within two weeks of admission 12.".33.35. They are 
replaced by resident flora after recovelY and discharge. Therefore the analysis was 
pelformed with E. coli considered separately, in order to facilitate determination 
of colonization with nosocomial bacteria, acquired during hospital stay, and their 
relation to the development of secondmy gram-negative pancreatic infection". The 
presence of intestinal E. coli did not increase the Jisk of pancreatic infection and 
mortality. Colonization with nosocomial gram-negative bacteria, however, 
significantly increases the risk of developing a secondmy endogenous gram-
negative pancreatic infection, as shown in this study. Moreover, when the same 
analysis was made for two treatment groups separately (subgroup analysis), results 
were similar to those of the whole group of patients, i.e. once gram-negative 
intestinal colonization occurs, the risk of developing a gram-negative pancreatic 
infection is increased, irrespective of SD treatment. 
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When E. coli were isolated from the pancreatic tissues (only 10% of patients with 
rectal E. coli), it was always found in a mixed infection with other gram-negative 
micro-organisms which had already caused infection at an earlier stage. In a 
clinical study on bacterial translocation in trauma patients, macrophages within 
mesenteric lymph nodes were found positive for Escherichia coli p-galactosidase, 
which suggested that most of these micro-organisms were ingested and killed by 
macrophagesJ6• This might explain why presence of intestinal E.coli did not 
increase the risk of development of gram-negative pancreatic infections in our 
study. 
Multiple organ failure due to gram-negative infected pancreatic necrosis is the 
major cause of later death in patients with severe acute pancreatitis. The 
development of gram-negative pancreatic infection increases the risk of mortality 
significantly'!. The OCCUll'ence of gram-negative intestinal colonization leading to 
an increased risk of the development of gram-negative pancreatic infection, 
therefore, causes a significant increased risk of mortality in these patients, as 
shown in this study. 
Gram-positive pancreatic infections are mostly not gut-dedved, i.e. exogenous, 
as is shown in tltis study. Infection of pancreatic necrosis with gram-positive 
nticro-organisms does not increase the risk of mortalitfl. 
Approximately 40% of the patients in whom colonization of the digestive tract 
with gram-negative bacteria occurred, developed a pancreatic infection. More than 
70% of these pancreatic infections developed within I week following the first 
isolation from the digestive tract. In an elegant experimental study on rats Wang 
et a1. described a significant increase of gut-originated bacteda in the pancreatic 
tissues in 20% of the animals 24 honrs after the induction of severe acute 
pancreatitis'o. 
Analysis of surveillance cultures of the digestive tract showed that colonization 
of the rectum is more predictive than colonization of the orophmynx. Surveillance 
cnltures from the stomach were taken in too small numbers to perform a reliable 
analysis. However gastric gram-negative colonization showed a resemblance to 
that of the oropharynx in patients in whom both sites had been cultured. These 
findings suggest that the the lower intestinal tract. i.e. small intestine, colon and 
rectum, serve as the most important reservoir from which translocation occurs 
towards the (ped) pancreatic tissues. Widdison et a1. already showed, in 
experimental studies, that pancreatic infections are reduced when the colon is 
enclosed in an impermeable bag". 
The evolution of the severity of rectal gram-negative intestinal colonization 
until the moment of gram-negative pancreatic infection showed an increasing 
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magnitnde with time, suggesting that an increase in the number of micro-
organisms is necessary for the break down of mucosal barriers and defense 
mechanisms before translocation towards distant organs can take place. This study 
shows that polymicrobial gram-negative intestinal colonization did not have an 
additional predictive value with regard to the risk of developing a gram-negative 
pancreatic infection, as compared to patients in whom only one species was found 
in the digestive tract, suggesting that the quantity is more important than the 
quality. Several investigators found a direct relationship between the quantitative 
increase of intestinal gram-negative micro-organisms and the magnitude of 
translocation, again implying intestinal bacterial overgrowth as an important 
promotor of translocation 19.20.37.39. This is in agreement with the finding that gram-
negative rectal colonization was only incidental or transient in ahnost all our 
patients who did not develop a gram-negative pancreatic infection. This may also 
be attributed to a difference of severity of the disease causing different grades of 
gut failure and impairment of innnunological defense mechanisms (average Imrie 
score on admission in tlus study: 4.5 with rectal colonization and infection in 
comparison to 2.7 without infection despite rectal colonization)'o. 
To date, prognostic data with regard to patients with severe acute pancreatitis who 
are at risk of developing a gram-negative pancreatic infection have been restricted 
to non-microbial parameters, i.e. high multiple laboratory scores (Inn'ie score) as 
well as extensive (peri)pancreatic necrosis demonstrated by contrast-enhanced 
CT21 .23 • Our results demonstrate that gram-negative pancreatic infections are 
preceded by intestinal colonization approximately one week earlier. 
CONCLUSIONS 
The appearance of intestinal colonization with gram negative nucro-organisms, 
increasing with time, is an early ominous predictive sign indicating that a serious, 
often fatal, gram negative pancreatic infection can probably be expected usually 
I week after the first intestinal occurrence. The presence of intestinal E. coli was 
not found to be of clinical importance with regard to the development of 
pancreatic infection, as well as with regard to mortality. 
Gram-negative intestinal colonization is an early prognostic parameter in patients 
in whom pancreatic infection has not yet occurred; it entails a significantly 
increased risk of pancreatic infections as well as higher mortality. Therefore 
increased efforts to free the digestive tract of nosoconual gram-negative micro-
organisms seems warranted. 
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EFFECTIVE REDUCTION OF GRAM-NEGATIVE INTESTINAL 
COLONIZATION WITH SELECTIVE DECONTAMINATION IN PATIENTS 
WITH SEVERE ACUTE PANCREATITIS 
Results of a prospective colonization study with separate analysis of E. coli 
Ernest J.T. Luiten, Wim C.J. Hop, Hubert Ph. Endtz, Hajo A. Bruitting 
SlIbmitted for Pllblication 
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ABSTRACT 
Since the presence of gram-negative intestinal flora significantly increases the risk 
to develop an aerobic gram-negative pancreatic infection, prophylaxis should be 
focused on eliminating tlus flora from the digestive tract. Investigations 
concerning effective antibiotics however have mainly been focused on the target 
organ, i.e. the inflamed pancreas 
Results from 1729 surveillance cultures of the digestive tract taken from 90 
patients with severe acute pancreatitis, during a randonuzed multicenter trial of 
selective decontanllnation (SD), were analyzed prospectively in order to evaluate 
the effect of SD on gram-negative intestinal colOluzation. 
The cumulative incidence of intestinal colonization with aerobic gram-negative 
nosconualmicro-organisms in the SD group (15 of 49 patients, 31 %) was signi-
ficantly decreased as compared to the control group (27 of 41 patients, 66%) 
(p=0.005). Also, the prevalence of gram-negative nosocomial pathogens in the SD 
group was significantly decreased as compared to the control group at nearly all 
days from day 10 until day 28. Escherichia coli, which was analyzed separately, 
was eIilninated within I week in all patients from the SD group and the prevalence 
remained more or less stable in the rectum (30-40%) and oropharynx (0-10%) in 
the control group. 
Although establishment of selective decontanunation was not aclueved in 3 of 
49 patients in the SD group, emergence of resistance to the drugs used in the SD 
regimen was not found. 
Selective decontamination can both effectively prevent and reverse gram-
negative intestinal colonization in patients with severe acute pancreatitis. 
Successfull reduction of gram-negative pancreatic infections and mortality in 
patients with severe acute pancreatitis with SD is aclueved through effective 
reduction of intestinal colonization. 
INTRODUCTION 
Antibiotic prophylaxis in the treatment of patients with severe acute pancreatitis 
has gained new interest. In the search of effective prophylaxis, the new broad-
spectrum antimicrobial agents have been investigated with regard to thei1' 
pancreas-specific pharmocokinetics and activity against the bacteria most 
frequently isolated from infected (peri)pancreatic necrosis'·'·3. In order to reach the 
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inflamed pancreas and surrounding tissues antibiotics are administered 
intravenous, although regional arterial perfusion has been reported also·. 
Aerobic gram-negative infection of (peri)pancreatic necrosis, which is the 
detelminant with regard to morbidity and mortality, occurs through translocation 
of microbes which originate from the gut5•6• Development of gram-negative 
intestinal colonization of the digestive tract is an ominous sign predicting a 
significant increased risk of secondary infection of pancreatic necrosis as was 
dicussed in chapter 4. 
Instead of focusing on protection of the target, i.e. the inflamed pancreas, 
antimicrobial prophylaxis may be more effective when primarily directed against 
the organ system from which the danger originates, i.e. the gUt'·9. Intravenous 
broad-spectrum antibiotics currently investigated in patients with severe acute 
pancreatitis-e.g. imipenem, cefuroxime, ceftazidime, ofloxacin, or pefloxacin-do 
not prevent gram-negative colonization of the digestive tract. Selective 
decontamination of the digestive tract (SO) however, is an enteral antimicrobial 
prophylaxis designed to prevent or eradicate, if initially present, oropharyngeal 
and gastrointestinal colonization with aerobic gram-negative potentially 
pathogenic micro-organisms, leaving the indigenous flora, which are thought to 
playa role in the resistance to colonization, predominantly undisturbed lO•ll • 
Several authors have reported about the effect of SO on intestinal colonization 
in ICU patients"·I7. The successfull reduction of gram-negative pancreatic 
infections and mortality in patients with severe acute pancreatitis with SO, as 
reported recently", should find its explanation through the effect of SO on 
intestinal colonization. However, apart from experimental studiesl9·21 , the latter has 
not yet been examined prospectively in patients with severe acute pancreatitis. 
In this controlled prospective colonization study results of systematic senu-
quantitative cultures of the digestive tract, taken from patients with severe acute 
pancreatitis, were analyzed to evaluate the effect of SO on intestinal colonization 
with aerobic gram-negative micro-orgmusms. 
PATIENTS AND METHODS 
The microbial intestinal flora of patients with objective signs of severe acute 
pancreatitis was prospectively monitored during a randonuzed clinical trial of 
adjuvant selective decontanUnation (Control group n=52 pts., Selective Deconta-
nunation group n=50 pts.). All patients suffered from severe acute pancreatitis 
according to a multiple laboratory criteria score (Imrie score :>3) and/or grade D 
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or E disease severity (Balthazar grades) using Contrast-Enhanced Computerized 
Tomography (CE_CT)22.2l. 
The SO regimen consisted of oral administration of colistin sulfate (200 mg), 
amphotericin (500 mg) and norfloxacin (50 mg) every 6 hours. A sticky paste 
containing 2% of the three SO d1'l\gs was smeared along the upper and lower gums 
every 6 hours and at the tracheostomy, if present. The aforementioned daily dose 
also was given in a rectal enema every day. 
Short-term (average 7.4 days) systemic prophylaxis with cefotaxime sodium 
(500 mg) was given every 8 hours until SO was established. i.e. elimination of 
nosocomial gram-negative micro-organisms from the oral cavity and rectum. 
Microbiology 
Surveillance cultures from the oropharynx and rectum were taken on admission 
and repeated twice weekly according to the original protocol. Samples were taken 
with a sterile cotton-tipped swab and cultured semi-quantitatively (1 +,2+,3+,4+ )". 
Identification was performed following routine microbiological procedures. 
Occurrence of gram-negative intestinal colonization of the digestive tract 
(orophmynx and rectum) was noted for each patient separately by recording the 
date of first isolation as well as duration of colonization of specific micro-
organisms. Colonization was defined as the presence of the same micro-organism 
in two or more consecutive cultures of samples, taken from the same site. The 
effect of SO on intestinal (resident) E. coli and gram-negative intestinal 
colinization with other aerobic gram-negative, hospital-acquired, potential 
pathogenic micro-organisms, here refened to as "gram-negative nosocomial 
micro-organisms", was studied separately in accordance with reports from 
others6,12,15.16,25. 
Patients in whom surveillance cultures had not been taken sufficiently to 
peliorm a reliable analysis were excluded from tltis analysis. Follow up was 
continued until death or until the risk of development of a pancreatic infection was 
considered absent-i.e. the patient was extubated and without supplementary 
oxygen therapy or infusions, on a regular diet, and mobilized on the ward. 
Selective decontamination was discontinued at that same time. 
Statistical analysis 
Percentages were compared using Fisher's exact test. The cumulative incidence of 
gram-negative intestinal colOltization, taking account of individual periods of 
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observation, was calculated using the Kaplan-Meier method. Comparison of these 
curves was done using the logrank-test, or the logrank-test for trend if appropriate. 
P-values ~O.05 (two-sided) were considered significant. 
RESULTS 
Of 102 patients who entered the study, 12 were excluded from this analysis as 
intestinal surveillance cultures had been taken insufficiently. A total of 1729 
surveillance cultures (control group: 41 patients, SD group: 49 patients) were 
analyzed. Qualitative analysis of surveillance cultures is presented in Table 1. 
Table 1. Qualitative Analysis of Gram-negative Intestinal Colonization. Incidence of Micro-
organisms in 90 patientsa 
Escherichia coli 
Nosocomial micro~organisms: 
Pseudomonas ael'llgillosa 
Klebsiella spp. 
Citrobacter spp. 
EnteJvbacter spp. 
Morgallella 11lorgallii 
Proteus ~pp. 
Serratia marescescens 
Acilletobacter spp. 
SD 
(no. patients) 
33 
15 
8 
4 
3 
control 
(no. patients) 
31 
27b 
16 
10 
5 
6 
4 
6 
4 
SD: selective decontamination group(n=49 patients), control: control group (n=41 patients). 
a: micro-organisms may occur in combinations in each separate patient. b: p=O.005. 
Gram-negative intestinal colonization did not occur in 18 patients (SD: 13 patients, control:5 
patients). In 30 of 64 patients E. coli was the only micro-organism isolated from the digestive 
tract (SD: 21 patients, control:9 patients). In the SD group rebound-colonization (only 2 
consecutive cultures) with Pseudomallos aeruginosa (1 patient) and Klebsiella (1 patient) 
occurred after discontinuation of SD. 
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The isolation of gram-negative nosocomial micro-organisms differed consistently 
between the control and the SD group. To compare prevalences after start of 
treatment, results of surveillance cultures have been grouped at three-day intervals. 
The results from oropharynx (Figure I a) and rectum (Figure I b) showed the same 
pattern. Initially (day 1), these gram-negative micro-organisms were isolated from 
these sites in a small propOltion (3-14%) of the patients in both groups. In the SD 
group the prevalence of positive samples in both oropharynx and rectum decreased 
to 0-2 % within 10 days of treatment. This proportion increased in the control 
group during the first week, then remained stable at 20-40%. From day 10 until 
day 28 the differences between the SD and control group were significant at all 
days with regard to the rectum (Figure Ib), and at all days but one (day 14: 
p=0.09) with regard to the orophmynx (Figure la). On day 1 gram-negative 
nosocomial pathogens were isolated in 13 patients (SD: 9 pts, control: 4 pts.) 
These micro-organisms were absent within 3 days in 6 out of 9 patients (78%) 
from the SD group as compared to lout of 4 patients (25%) in the control group 
(p=0.22, n.s.). 
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Figure 1. Results from surveillance cultures along time: Prevalence of aerobic granHlegative 
micro-organisms (except E. coli) from oropharynx (la) and rectum (lb); the differences between 
control and SD group from day 10 until day 28 are significant at all days for rectal and all days 
but oue (day 14: p=O.09) for oropharyngeal cultures. Prevalence of E. coli isolated from 
oropharynx (Ie) and rectum (ld). ----: control group, --: SD group. 
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E. coli was initially isolated from two or more consecutive cultures in 33 of 49 
patients receiving SD (Table I). In all of these patients E. coli was eliminated 
within 7 days SD treatment without later recurrence (Figure lc/d). In the control 
group the proportion of positive cultures from the orophatynx remained stable at 
more or less 10% (Figure Ie). Rectal isolation of E. coli in the control group 
remained at high levels (30-40%) with a temporary (borderline significant, 
p=0.057) increase up to 58% at the beginning of the second week (Figure Id). 
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Figure 2. Cumulative incidence along time of gram-negative intestinal colonization according 
to treatment group; p=O.005. ----; control group, --; SD group. 
Gram-negative intestinal colonization in the control group occuned in 27 of 41 
(66%) patients. In 22 of these 27 patients (81 %) colonization occurred within two 
weeks of admission. The cumulative incidence of gram-negative intestinal 
colonization with gram-negative nosocomial micro-organisms according to 
treatment group is shown in Figure 2. In the SD group gram-negative intestinal 
colonization occurred in 15 of 49 (31 %) patients, who are discussed in the 
undermentioned (p=0.005). One of these patients died after 4 days. In nine patients 
colonization was found during the first week only, followed by establishment of 
selective decontamination. In two other patients short-term rebound colonization 
(2 consecutive cultures) occurred after discontinuation of SD during the 4th week 
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(Figure 2). In another patient, in whom colonization during the first week with 
Pseudomollas aerugillosa was eliminated only after 18 days, recolonization with 
Pseudomollas aerugilfosa was found on the 31th day and persisted until death after 
38 days. The Pseudomollas strain was susceptible to norfloxacin on both 
occasions. In the remaining two patients initial presence of E. coli was eliminated 
by SD. In both patients selective decontamination was established for a few weeks. 
However in one of them, who survived, transient colonization after the 6th week 
was followed by transient pancreatic infection with Serratia marcescelfs resistant 
to the components of the SD regimen when first isolated. In the other patient, in 
whom intially selective decontamination was established, intestinal colonization 
with Pseudomollas aerugillosa-susceptible to norfloxacin-occurred after 31 days 
was followed by a fatal pancreatic infection. 
The lImie score at enrollment in the study appeared to correlate very sU'ongly with 
the incidence of gram-negative intestinal colonization along time, especially in the 
control group (p=O.OOl) (Figure 3). 
r-- -- ______ r---------------- -----------
r-' 
Figure 3. Cumulative incidence along time of gram-negative intestinal colonization in the 
control group (left) and selective decontamination (SD) group (right), according to Inuie score 
(1,0-2; II, 3-4; III, >4) at enrollment in the study. Control group scores: T, 20 patients; II, 13 ; Ill, 
8; P ~~=0.001, SD group scores: T, 15 patients; II, 22; III, 12; P ~~=0.53. 
DISCUSSION 
Gram-negative pancreatic infection, which appars a very important factor with 
regard to mortality in patients with severe acute pancreatitis, is gut-originated6. 
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This study demonstrates that SD can both effectively prevent and reverse gram-
negative intestinal colonization in patients with severe acute pancreatitis. The total 
number of patients in whom gram-negative intestinal colonization occurred 
(cumulative incidence) of 66% in control group patients is comparable to results 
reported by Aerdts et aI. and Saunders et aI. however higher than reported by 
Tetteroo et aI. [4.26.27. The actual number of patients or samples containing gram-
negative nosocomial pathogens (prevalence) increased along time to a lower level 
than the rates (greater than 80% at seven days) as found by Stoutenbeek-who 
however used a historic control group-and others 12·". Differences probably reflect 
a difference of disease and severity of illness. The latter is underlined by our study 
which showed that the probability of occurrence of gram-negative intestinal 
colonization increases with higher Imrie scores on admission. A lower cumulative 
incidence in the SD group reflects effective prevention of gram-negative intestinal 
colonization whereas the prevalence is also affected by reversal by SD of gram-
negative intestinal colonization after its occurrence. When comparing differences 
between percentages of patients with gram-negative intestinal colonization, the 
measure of prevalence probably is of less clinical importance as compared to the 
cumulative incidence. Tltis is due to the fact that the first measure is greatly 
influenced by the composition of the patient groups wltich are sampled at the 
various time points. 
Ledingham et aI. only found an increasing prevalence of colonization in the 
upper gastrointestinal tract, i.e. throat and stomach, which can be explained by the 
fact that results from rectal colonization included the presence of (resident) 
E. coli13• Presence of intestinal E coli was found not to be of clinical importance 
with regard to development of pancreatic infection in contrast to intestinal 
colonization with other gram-negative nosocomial nticro-organisms as has been 
reported previously". Because administration of SD is aimed to prevent 
development of gram-negative pancreatic infection, the effect of SD on presence 
of intestinal (resident) E. coli was therefore studied separately from other gram-
negative nosocomial nticro-orgmtisms sintilarly as reported by others 12.15.[6.". 
Approximately I week was required to free the intestine from gram-negative 
nosocomial micro-organisms as was also reported by Ledingham et aI.I3. However, 
we did not find a difference between establishment of selective decontamination 
of the upper and lower intestinal tract which can be explained by additional rectal 
adntinistration of SD medication in Olll' study. As colonization of the rectum has 
been demonstrated to be of major importance with regard to later development of 
a gram-negative pancreatic infection6, rectal administration of SD drugs is 
essential in patients with severe acute pancreatitis. After 3 days already 78% of the 
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patients, who presented with intestinal gram-negative pathogens on day 1 and who 
received SD, were without these pathogens as compared to 25% of the patients in 
the control group. However this difference did not reach statistical significance, 
possibly due to small numbers. Rebound colonization after withdrawal of SD-
medication, as found occasionally in two patients, did not offer a problem as was 
observed by Tetteroo et al.27. 
In order to provide additional cover before SD was fully established, 
cefotaximesodium was used as a short-term (average 7.4 days) systemic 
prophylaxis, as it had been used most often in SD trials!'·I7,'6.", The question has 
been raised whether efficacy is actually conferred by the parenteral agent rather 
than the regimen of oral antibiotics'9,3o. Although Widdison et a!. demonstrated 
that early administration (12 hI's ii'om onset) of intravenous cefotaxime or 
levamisole in cats was indeed effective in treating-however ah'eady established-
pancreatic infection3!,3', until now however none of the four prospective clinical 
trials33-36 using only adjuvant systemic intravenous antibiotic prophylaxis has 
demonstrated both reduction of development of gram-negative pancreatic infection 
as well as reduction of mOitality in patients with severe acute pancreatitis. (Results 
from these studies using intravenous antibiotic prophylaxis are discussed in detail 
in chapter 633 -36,) Moreover, van Saene reported emergence of resistance-after 4 
days intravenous administration-against cefotaxime, although higher dose of 50-
100 mg/kg/day, of several aerobic gram-negative micro-organisms, which are 
frequently found in infected pancreatic necrosis, e,g Pselldomonas species, 
Acinetobacter species, Enterobacter cloacae and Citro-bacter speciesJ7. Although 
BUchler et a!. calculated that cefotaxime reached sufficient concentrations in vital 
pancreatic tissue of patients undergoing mainly elective pancreatic surgety!, 
Foitzik et a!. however found that concentrations of antibiotics in the pancreas, e.g. 
cefotaxime, are low during the early phase of experimental acute necrotizing 
pancreatitis, depending on changes in pancreatic tissue morphology and capillary 
blood flow3. They also showed that prophylactic use of cefotaxime or oral 
antibiotics alone were not able to reduce pancreatic infection in rats in contrast to 
the combination of both'o. 
Failure of SD to eliminate and prevent gram-negative intestinal colonization 
may be due to: 1) insufficient intestinal concentration (below the MIC) due to 
insufficient administration, intestinal absorption or inactivation by faeces, 
2) selection of resistant organisms in the gastro-intestinal tract, 3) aquisition and 
colonization of resistant micro-organisms from the hospital environment, 4) de 
novo emergence of antimicrobial resistance during SD. 
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Norfloxacin is absorbed incompletely from the digestive tract and therefore 
reaches high faecal concentrations: at an oral dose of 200 mg daily Aerdts 
maesured concentrations of 100 microgram per gram faeces exceeding the MlC 
of even the least suseptible aerobic gram-negative micro-organisms3S• Colistin was 
given in a relatively large amount (800 mg daily) because of the marked 
inactivation of polymyxins in the digestive tract39.40. When combined with other 
oral antibiotics even lower doses have been reported to reach sufficient intestinal 
concentrations40. Therefore inadequate administration causing insufficient 
intestinal concentration may have been the cause of SO-failure in two patients 
dying of gram-negative pancreatic infection caused by a Pseudomonas strain 
susceptible to the components of the SO regimen. 
Acquisition of resistant hospital strains, as occurred in one patient, endanger 
every patient admitted, especially on an lCU. Although interpreted as failure of 
any prophylactic antimicrobial regimen, i.e. SO, it reflects the selective pressure 
of antibiotics and the appropriateness of (previous) antibiotic use. Moreover, local 
infection control practices are important in the transmission of nosocomial 
pathogens in an lCU4!. A major problem in the prophylactic use of antibiotics is 
the risk of selection of resistant microbes and fungi. With SO, selection or de 
novo emergence of resistance is at least theoretically ruled out once the aerobic 
gram-negative micro-organisms have been eliminated: if complete intestinal 
elimination is achieved no resistance potential is present. An overall increase in 
antibiotic resistance amongst the aerobic gram-negative micro-organisms by the 
use of SO is either rare or absent!4.!5.4241. 
Since de novo emergence of resistance to the quinolones during SO is incidental 
and with absence of possible systemic hazardous side-effects when absorbed as 
well as their low costs, they appear to be suited for S038.45.47. 
CONCLUSIONS 
Since acute pancreatitis induces intestinal bacterial overgrowth and secondary 
pancreatic infections are gut-originated, prophylaxis should be focused on 
prevention of gram-negative intestinal colonization6.4'. Selective decontamination, 
including rectal administration of the same drugs, has been shown both to 
effectively prevent acquisition of gram-negative nosocomial micro-organisms as 
well as to rapidly reverse occasional initial gram-negative intestinal colonization 
in patients with severe acute pancreatitis thereby reducing the risk to develop a 
life-threatening gram-negative infection of (peri)pancreatic necrosis. 
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HISTORY 
The use of antibiotics in acute pancreatitis has been continously debated for more 
than half a century, In 1950 Lewis and Wangensteen reported reduced mortality 
in dogs with acute hemorrhagic pancreatitis treated with penicillin', Persky et al. 
demonstrated that aureomycin, given orally, resulted in 100 per cent survival after 
bile-induced necrotizing pancreatitis in mongrel dogs', Cultures of pancreatic 
necrosis from non-surviving dogs treated without antibiotics, showed an increase 
of secondary pancreatic infection, especially with Clostridia, Subsequently, they 
found a moderate reduction of mortality with polyvalent clostridial toxoid, 
neomycin and polymyxin B3, 
Byrne and Joison, however discussing the primary role of bacteria in the 
pathogenesis of necrotizing pancreatitis, found that neomycin, tetracyclin, 
penicillin and sulfonamide instilled in a closed duodenal loop, prevented the onset 
of necrotizing pancreatitis·. Thai et al. mentioned increased survival when 
Escherichia coli-induced necrotizing pancreatitis was treated with aureomycin', 
Similar results were also reported when antibiotics were used in germ-free dogs 
with necrotizing pancreatitis, casting some doubt on the essential role of bacteria 
in the pathogenesis'. 
While many investigators supported the clinical use of antibiotics in acute 
pancreatitis, Kodesch and DuPont in 1973 probably were the first to express 
sceptiscism about the protection against infectious complications 7-10, A few years 
later three controlled clinical trials with ampicillin in patients suffering from, mild, 
acute pancreatitis showed no benefit"-13 , 
Since advances in critical care have greatly reduced the incidence of death 
caused by the early cardio-pulmonary sequelae of severe acute (necrotizing) 
pancreatitis, secondaty pancreatic infections currently have emerged as the leading 
cause of mortality and morbidity14-18, 
After a decade of nihilism in the face of infected pancreatic necrosis, there is 
now optimism that infection may be preventable due to results of recent controlled 
clinical trials based on knowledge of penetration of different antibiotics into the 
pancreatic tissues and on data regarding the microbial flora most frequently 
isolated from pancreatic necrosis,·,17-30, 
82 
Role of ProphylacHc Allfibiotics/SD 
INCIDENCE 
Secondary infections (i.e, infected necrosis, pancreatic abscess or infected 
pseudocyst) complicate 3-12% of the cases with acute pancreatitis 17,21,29-34, It is 
estimated that severe acute (necrotizing) pancreatitis develops in 10-20% of 
patients with acute pancreatitis and secondmy infection of (peri)pancreatic 
necrosis occurs in 40-70% of these patients l ,,22,26,29,30,33-42, Gram-negative aerobic 
micro-organisms are isolated in 50-70% from cultures of infected (peri)pancreatic 
necrosis suggesting an enteric origin l ,,27-30,J4,37,40, Development of gram-negative 
infection of (peri) pancreatic necrosis is, apart from the Itmie score, the most 
important parameter determining outcome as compared to patients in whom 
infection does not (i.e, sterile necrosis) occur", Infection of necrosis with only 
gram-positive micro-organisms has the same prognosis as necrosis remaining 
sterile", Gram-negative infection of pancreatic necrosis has been found to be 
preceded by intestinal colonization with identical gram-negative micro-organisms 
both experimentally and clinically+l-", 
Beger et a1. showed that infection of pancreatic necrosis increases with time 
during the course of the disease I', However, only data of patients who were 
operated, were analyzed, We also found that the incidence of infected necrosis, 
when analyzing the bacteriologic status at the first laparotomy, increased with 
time, from 9% during the first week to 50% during the second and third week, as 
has also been reported by others",26.53, Mortality due to infection of pancreatic 
necrosis is significantly increased from 31 % within two weeks to 77% thereaftet23, 
ROLE OF ANTIDIOTICS 
Since infection of pancreatic necrosis is a secondary phenomenon, prophylactic 
antibiotics should be administered at an early stage of tissue injury before 
infection has developed, i.e, from the onset of the disease, Antibiotics should 
probably only be used in patients with severe acute pancreatitis (three or more 
positive Imrie signs), since mild acute pancreatitis is a self-limiting disease 
irrespective of the type of medical treatment'-I-57, It is currently unknown whether 
antibiotics are more useful in acute pancreatitis due to gallstones or from alcohol 
abuse, 
Three early controlled clinical trials using prophylactic ampicillin in patients 
with mild mostly alcohol-induced pancreatitis showed no benefie 1-13, However, 
ampicillin is a poor antibiotic choice for acute pancreatitis as it does not penetrate 
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the pancreas and, perhaps more importantly, does not cover the gram-negative 
micro-organisms most frequently isolated from infected pancreatic necrosis, i.e. 
Escherichia coli, Pel/dOli/aliaS, Klebsiella >1Jecies and Ellferobacter species 
(Chapter 2: Table 4)14.22-24.26.27. Above all the patients recruited only had mild 
disease not bearing the risk of pancreatic infection. 
Based on pharmacokinetic data on several antibiotics from human pancreatic 
juice or pancreatic tissues from animals, several investigators have speculated 
about appropriate antibiotics to treat patients with acute pancreatitis 17. 58-61. 
An important contribution towards better understanding of antibiotic penetration 
into human pancreatic tissue was made by BUchler and co-workers in 1992". TIley 
calculated the potential clinical effectiveness of ten different bactericidal 
antibiotics, taking into account a) type and frequency of bacteria commonly 
involved in human pancreatic infections, b) pancreatic tissue concentrations of 
these antibiotics 120 minutes after intravenous infusion and c) the percentage of 
inhibited bacteriological strains, in 89 patients undergoing elective pancreatic 
surgery for acute pancreatitis, chronic pancreatitis or pancreatic cancer. Three 
groups of antibiotics were established: group A, substances with low pancreatic 
tissue concentrations (netilmycin, tobramycin), which were below the MIC of most 
bacteria; group B, with pancreatic tissue concentrations which were sufficient to 
inhibit some but not all bacteria (mezlocillin, piperacillin, ceftizoxime, 
cefotaxime); group C, antibiotics with high pancreatic tissue concentrations as 
well as high bactericidal activity against most micro-organisms found in pancreatic 
infections (ciprofloxacin, ofloxacin, imipenem). Metronidazole showed good 
penetration into the pancreas, but was not included in the efficacy analysis because 
of its small bactericidal spectrum almost exclusively against anaerobes. 
It was reconmlended to be included in treatment regimes with antibiotics which 
are not effective against anaerobes, i.e. group B antibiotics. However, only 9% of 
the samples (8/89) were taken from patients with acute pancreatitis analyzing only 
3 different antibiotics, i.e. mezlocillin, netilmycin and metronidazole. Because 
pancreatic tissue concentrations for these antibiotics were not different from 
patients with chronic pancreatitis or pancreatic cancer it was concluded that there 
were no significant differences in the pancreatic tissue concentrations with respect 
to the underlying disease for the other seven antibiotics analyzed. However, 
Foitzik et al. demonstrated that antibiotic tissue concentrations may not be 
consistent from one agent to another, because of changes in pancreatic tissue 
morphology and capillary blood flow in experimental acute pancreatitis, and that 
efficacy cannot be estimated solely on the basis of their pharmacology and 
microbiological properties62 • 
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Bassi et al. examined whether antibiotics excreted by the normal pancreas 
(imipenem, mezlocillin, gentamycin, amikacin, pefloxacin and metronidazole) are 
also excreted in necrotic pancreatic tissue". Following parenteral administration 
of antibiotics, serum and samples of pancreatic necrosis, obtained by computed 
tomography (CT)-guided needle aspiration, intraoperatively, and from surgical 
drains, were collected simultaneously at different time intervals from twelve 
patients suffering from severe acute pancreatitis. Although all of the antibiotics 
reached the necrotic tissue, only pefloxacin and metronidazole concentrations 
consistently exceeded the MICs for the micro-organisms most commonly isolated 
from infected necrosis. Mezlocillin and imipenem inconsistently attained levels 
greater than the MICs, although the concentration of imipenem seemed to enhance 
by repeated administration. Aminoglycosides levels were always inadequate. 
Controlled clinical trials of intravenous antibiotics 
When choosing a prophylactic antibiotic in order to prevent secondary infectious 
complications in patients with severe acute pancreatitis, the ideal drug should be 
characterized by a) effectiveness against commonly involved micro-organisms, b) 
ability to penetrate into pancreatic tissue and pancreatic exocrine secretions, c) 
ability to reach therapeutic mean inhibitory concentrations (MIC) in pancreatic 
tissue, (peri)pancreatic necrosis and peripancreatic fluidcollections during severe 
acute pancreatitis, d) demonstrated clinical capacity of reducing the development 
of pancreatic infection and, e) cost-effectiveness and low adverse reactions. 
Based on the results reported by BUchler et al.", a controlled multicenter trial 
of imipenem prophylaxis in patients with necrotizing pancreatitis was conducted 
Pederzoli et al. 2 •• During a two-and-a-halfyear period 74 patients were included, 
based on presence of detectable pancreatic necrosis demonstrated by contrast-
enhanced computed tomography (CE-CT) within 72 hours of onset of symptoms. 
Patients were randomized to receive standard medical treatment without (n=33 
patients) or with adjuvant imipenem (41 patients) for 2 weeks (500mg evelY 8 
hours intravenously). Ranson scores, which were not used as an inclusion 
criterium, ranged from 3 to 6 (mean 3.7). Almost fifty percent of the patients only 
had mild necrosis (less than 30%) as found on CE-CT, bearing a lesser risk of 
infection, and of the sixteen patients with severe pancreatic necrosis (more than 
50%) only two were randomized to the control group. Nevertheless a significant 
reduction of pancreatic sepsis 02.2% versus 30.3%) and non-pancreatic sepsis 
(14.6% versus 48.5%) was observed. Unfortunately separate results with regard 
to reduction of the total number of patients with aerobic gram-negative infection 
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of necrosis, which is the detenninant of mortality, cannot be fully evaluated from 
the data reported. However mortality (7.3% versus 12.1 %) was not different, but 
overall mortality (9.4%) was rather low probably reflecting the incidence of less 
severe disease. 
Based on their own results regarding behaviour of antibiotics in human pancrea-
titis, Bassi and co-workers pelformed a prospective trial during a 6-year period in 
60 patients with severe acute pancreatitis who were administered either pefloxacin 
(400mg evelY 12 hr) or imipenem (500mg every 8 hr) for 2 weeks. Patients were 
included if C-reactive protein (CRP) values were above 100mgll and more than 
50% pancreatic necrosis was confirmed by contrast-enhanced computed 
tomography (CE-CT) (Bassi et aI., submitted for publication, with permission). 
The incidence of infected pancreatic necrosis, which mainly occurred after the 
second week when antibiotic treatment was already stoppped, in the pefloxacin 
group (34%) was higher as compared to the imipenem group (10%) (p<0.05). 
Mortality also was higher in the pefloxacin group (24%) as compared to the 
imipenem group (10%), although not statistically significant,. Despite its 
theoretical potential, pefloxacin was not found to be a valid alternative to 
imipenem in severe acute pancreatitis, which once again stresses the necessity of 
proven efficacy by prospective clinical trials before antibiotics are widely adopted 
as prophylaxis in this disease. 
Sainio et al. reported a significant reduction of mortality in 60 patients, recruited 
during a 4-year period, with acute necrotizing pancreatitis using cefuroxime 
(4.5g/day)"'. This was not associated with a reduction of pancreatic sepsis. 
Unfortunately the authors were forced to change from cefuroxime to alternative 
antibiotics in two-thirds of the patients after 9 days (2-28) and to initiate antibiotic 
therapy after 6 (2-16) days, on the basis of presUlned or documented infection, in 
23 of the 30 patients initially randomized to no therapy. The incidence of urinary 
sepsis was significantly decreased in the group of patients treated initially with 
cefuroxime. Confounding factors may have been responsible for the reported 
statistically significant reduction of mortality as was already noted by others65~69. 
In contrast to third generation cephalosporins, which achieve adequate pancreatic 
tissue levels, the pancreatic phannocokinetics of cefuroxime are unknown and its 
failure to reduce infection of pancreatic necrosis in this study may indicate that 
pancreatic penetration is poor. However cefuroxime was chosen because of the 
susceptibility of Escherichia coli and Staphylococcus aureus, the latter which is 
a common cause of sepsis in their intensive care unit, thereby acknowledging the 
possibly of a lesser degree of penetration in pancreatic necrosis. 
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A small but well-designed controlled study of 26 patients, enrolled during a 4-year 
period, conducted by Schwarz et al. using ofloxacin and metronidazole reported 
no prevention of pancreatic infection?o. Interestingly, the total number patients 
who developed an aerobic gram-negative pancreatic infection was lower in the 
treatment group (1/13 patients, 7%) as compared to the control group (6/16 
patients, 46%) (p=0.07). However, because of the few patients recruited in this 
study, the possibility of not reaching statistical significance may have biased the 
conclusions (type II error). 
A controlled study by De1censerie and colleagues, which recruited 23 patients 
with alcohol-induced severe acute pancreatitis during a 5-year period, using 
ceftazidime, metronidazole and amikacine for only 10 days, reported a reduction 
of overall episodes of sepsis7l. However, reduction of pancreatic infections, 
particularly reduction of aerobic gram-negative pancreatic infection was not 
achieved. Conclusions from this study should also be intelpreted with caution due 
to the very small number of patients included and because amikacin, an 
aminoglycoside, is from a class of drugs that does not adequately penetrate the 
pancreas. 
Clinical study of intra-arterial antibiotics 
Takeda and colleagues studied reduction of pancreatic infection by continuous 
regional arterial infusion (CRA!) with antibiotics, which were combined with 
nafamostat, a protease inhibitor in an uncontrolled non-randomized study 72. 
During a five-year period 53 patients with severe acute pancreatitis were referred 
from elsewhere and divided in tln'ee groups: Group I, 16 patients who were 
referred >8 days after disease onset, received intravenous nafamostat and 
antibiotics (5 different drugs); Group II, 22 patients refen'ed within 7 days, during 
the first three-and-a-half year, received nafamostat via CRA! for 3 to 5 days and 
intravenous antibiotics (antibiotics not specified); Group III, 15 patients referred 
within 7 days during the last one-and-a-half year of the study, received both 
nafamostat and imipenem (500mg every 12 hr) via CRA! for 3 to 5 days. The 
incidence of infection of pancreatic necrosis in group III (0%) was significantly 
lower than those in group I (50%) and group II (23%). Although mortality rates 
in group II (14%) and group II1 (7%) were significantly reduced, as compared with 
that in group I (44%), both are not significantly different from each other. 
However, the design of the study, the different antibiotics used, the short period 
during which CRA! was performed and, the simultaneous use of nafamostat, a 
protease inhibitor, may have intelfered with the results and the clinical applicabili-
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ty of this technique may have its drawback. Hayashi and colleagues reported 
siguificant improved survival rate, prevention of pancreatic infection and 
decreased serum levels of phospholipase A, activity and endotoxin in an expeli-
mental study of CRAI using flomoxef in dogs with acute pancreatitis, as compared 
to intravenous use or a control group73. Moreover, they found only a little 
beneficial effect of intravenous administration as compared to animals treated 
without antibiotics, suggesting that the intravenous route may be less sufficient. 
However, the importance of these results is limited due to the velY short follow up 
(only 36 hours). 
Controlled clinical trial of enteral antibiotics: selective decontamination 
Following better knowledge about infected necrosis, its prevalent flora suggesting 
an origin in the gut, experimental evidence concerning the protective effect of 
reduction of intestinal flora and successful clinical reduction of gram-negative 
intestinal flora from the digestive tract, a multicenter controlled randomized 
clinical trial using selective decontamination in 102 patients with severe acute 
pancreatitis, enrolled in a 3-year period, was conducted in the Netherlands 14.2l.74-82• 
All patients had severe acute pancreatitis defined by Inn'ie score ;,3 and or 
Balthazar grade 0 or E (Chapter 2: Table 1)75.83. The selective decontamination 
reginlen consisted of oral, and rectal (enema containing daily dose), administration 
of colistin sulphate (200mg), amphotericin (500mg) and norfloxacin (50mg) every 
6 hours. Also a sticky paste with the three dmgs was smeared along the gums and 
tracheostomy, if present. A short term systemic prophylaxis (mean 7.4 days), using 
cefotaxime, was given until the digestive tract was successfully selectively 
decontaminated. Selective decontamination was discontinued as soon as the risk 
of acquiring an infection was negligible-i.e. extubated and without supplementalY 
oxygen therapy or infusions, on regular diet and mobilized on the ward. 
Selective decontamination (SO) significantly reduced overall mortality tln'ough 
its significant effect on gram-negative pancreatic infection and late mortality 
(Chapter 2: Figure I, Table 3). The Imrie score proved to be very valuable in 
identifying patients with increased risk of development of gram-negative 
pancreatic infection and also at risk of dying2l.4'. CT-findings using Balthazar 
grades were less accurate as they tend to overestimate the severity of severe acute 
pancreatitis (Chapter 2: Figure 2, Table 3). SO reduced mortality in treated 
patients with three or more positive Imrie signs from 55% to 31 % with a 95% 
confidence interval for the difference in mortality ranging from 0% to 48%. 
Failure of SO to successfully maintain clearance of gram-negative nosocomial 
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flora from the digestive tract was seen in four patients, followed by development 
of a pancreatic infection. Suggested SO-induced overgrowth of gram-positve flora 
was not found"·ss. 
There is general agreement that infected (peri)pancreatic necrosis is an absolute 
indication for operation, which may need to be repeated!4.".J7.J,.,6.". Even after 
surgely, infected necrosis carries a threefold higher mortality rate (range 15-82%) 
in contrast to sterile necrosis,,·S7·8'. A significant lower number of repeated 
laparotomies and lower surgery-related complication rate were achieved in 
patients treated with SO through a significant reduction of gram-negative 
pancreatic infections'J. More than 70% of these infections occurred within 1 week 
of first isolation from the digestive tract". 
Persky and collegues in 1951 were way ahead of their time when they found a 
much greater effectiveness of the oral as compared to intravenous aureomycin and 
postulated that the micro-organisms responsible for secondmy infection of the 
pancreas in dogs originated from the intestine'. Favourable effects have been 
reported on the outcome of experimental necrotizing pancreatitis in rats, reducing 
the intestinal flora by means of colectomy, caecostomy , intestinal lavage with 
addition of oral kanamycine or colonic irrigationS!.9o. Two recent experimental 
studies with selective decontamination reported reduction of pancreatic 
infection"·9!. 
Since acute pancreatitis induces intestinal bacterial overgrowth and secondary 
pancreatic infections are gut-derived, the gut serves as the "motor" of pancreatic 
sepsis'!)'52.9'. Intravenous antibiotic prophylaxis, i.e. imipenem, does not affect the 
colonic pool of bacteria47. In order to nip the danger of secondary pancreatic 
infection in the bud, early elinlination of gram-negative micro-organisms from the 
digestive tract by means of SO seems the most logical and effective step to reduce 
morbidity and mortality in severe acute pancreatitis. 
OTHER PROPYHLACTIC STRATEGIES 
Initial enthousiasm for peIitoneal lavage was dampened by a large controlled 
clinical trial showing no effect on the outcome of severe acute pancreatitis9J.97• 
However, inspiring results were reported by the late J.H.C. Ranson, comparing 
long (7 days) versus short (2 days) peritoneallavage98• The operative technique 
advocated by Beger et al. consists of necrosectomy and continuous closed 
postoperative lavage of the lesser sac33• Currently an overall mortality rate of 
15.4% is reported in case of infected pancreatic necrosis'". Initially a lower 
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mortality rate of 8.4%99 was reported including results of patients operated for 
sterile necrosis. The very impressive results in case of sterile necrosis necrosis 
may be partly due to the excessive lavage, initially with more than 24 liters per 
day, preventing secondary pancreatic infection. 
RECOMMENDA TIONS FOR TREATMENT 
Only patients with severe acute pancreatitis (i.e. three or more positive limie 
signs) will benefit from antibiotic therapy. As infection can occur ali'eady during 
the first week after onset of the disease, prophylactic antibiotics should be given 
as soon as possible after admission and diagnosis. Antibiotic prophylaxis should 
be continued until the risk of pancreatic infection is absent. 
Up to now selective decontamination of the digestive tract (colistin, 
amphotericin and norfloxacin) combined with a short term (average 7 days) 
systemic prophylaxis of cefotaxime, until selective decontamination is established, 
is most effective in reducing morbidity as well as mortality. 
The intravenous prophylactic antibiotics used, should adequately penetrate 
(peri)pancreatic tissues and should be effective against the prevalent flora found 
in infected necrosis. However inripenem, which meets these criteria, has only 
proven its efficacy with regard to reduction of pancreatic infection but not 
mortality. 
Further controlled multicenter trials with adjuvant autibiotic prophylaxis, 
including large numbers of patients with severe acute pancreatitis after proper 
severity stratification, are warranted in order to answer the many open questions. 
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CHAPTER 7 
SELECTIVE DECONTAMINATION FOR SEVERE ACUTE PANCREATITIS: 
SUMMARY 
Ernest IT. Luiten, Rajo A. Bruining 
Adapted from: Luiten ElT, Bntining HA. Selective decontamination versus 
antibiotics. A critical review. In: Neoptolemos lP ed. Balliere's Clinical 
Gastroenterology: Issue on Acute Pancreatitis. In press. 
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INTRODUCTION 
Acute pancreatitis is an acute inflammatOlY process of the pancreas, with vmiable 
involvement of peripancreatic tissues or remote organ systems. Despite a wide 
variety of etiology, gallstones and alcohol represent more than 75% of all etiologic 
causes l . 
According to the Atlanta clinically based classification of acute pancreatitis, 
75% of all patients only suffer from a mild acute disease with minimal organ 
dysfunction with an uneventful recovery il1'espective of the type of medical 
treatment'. However, during the initial 24 to 48 hours after onset of symptoms 
about 20%-30% of all patients with acute pancreatitis develop a severe clinical 
course. Severe acute pancreatitis is associated with organ failure andlor local 
complications, such as necrosis, abscess, or pseudocyst. Tllis severe acute disease 
is further characterized by 3 or more InuielRanson criteria, or 8 or more APACHE 
II points'. The rapid development of organ dysfunction and (peri)pancreatic 
necrosis is initiated by "premature" intrapancreatic activation of pancreatic 
enzymes wllich trigger a systenlic inflannnatory response evoked by host-derived 
inflammatOlY mediators. With agressive intravenous fluid replacement and intensi-
ve care more patients pass through these critical early stages and later secondm'y 
infection of (peri)pancreatic necrosis currently is the major cause of death in 
patients with severe acute pancreatitis. 
INFECTION OF (PERl)PANCREATIC NECROSIS 
Infection of (peri)pancreatic necrosis occurs in 40-70%].6 and the incidence 
increases with larger amounts of necrosis3.'. Beger et al. 3 performed a nlicrobio-
logical analysis of (peri)pancreatic necrosis obtained during the first necrosectomy 
from 114 patients who were operated on because of development of necrosis. They 
demonstrated that the incidence of infected (peri)pancreatic necrosis increased 
with time from 24% during the first week up to more than 70% during the third 
week3• A similar analysis pelformed in only 24 patients from the control group of 
our study, who were operated on because of clinical deterioration despite intensive 
care or because of proven infection of (peri)pancreatic necrosis, showed a more 
or less comparable (small numbers of patients) increase from 12% during the first 
week up to 50% during the third week. However, patients who are found to have 
sterile necrosis at first necrosectomy may develop infection of (peri)pancreatic 
necrosis later during the course of the disease which is not taken into account in 
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this incidence analysis. Moreover, patients whose deteriorating condition demands 
a (fIrst) surgical intervention, however, later during the course of the disease are 
likely to have developed an infectious complication during hospital stay. A lower 
incidence of infected necrosis at first laparotomy during the first week is also 
influenced by the number of patients who were operated on despite sterile 
necrosis, which used to be an indication for surgical intervention during the last 
decade. An analysis of all 52 patients who were not administered selective 
decontamination in our study (control group), thus including also the remaining 
patients who did not need surgery, showed that the true incidence of gram-
negative infection of (peri)pancreatic necrosis remained stable at approximately 
9% (range, 10%-7%) during the first, second, third, and fourth week, respectively, 
and 18% when infection occurred after the fourth week. Mortality due to the 
development of a gram-negative pancreatic infection occurred more than 2 weeks 
later (average 15 days, range 0-71 days). If patients survived despite a gram-
negative pancreatic infection, hospital stay was significantly longer (chapter 3). 
In 1986 Beger et aI.' underlined to distinguish patients with infected from sterile 
necrosis because of different morbidity and mortality. Ever since, patients with 
infected necrosis have been dealt with as one group, regardless of the specific flora 
cultured. However, the prognosis for patients with infected necrosis differs 
according to the bacteria isolated, as shown in dIOpter 3. Cultures in cases of 
infected (peri)pancreatic necrosis most frequently yield a polymicrobial flora, with 
a preponderance of aerobic gram-negative micro-organisms, suggesting an enteric 
origin3.6. Mortality is significantly higher once aerobic gram-negative infection 
occurs as compared to development of infection with only gram-positive micro-
organisms (chapter 3). 
CLINICAL TRIALS WITH PROPHYLACTIC SYSTEMIC ANTIBIOTICS 
Since infection of pancreatic necrosis, especially aerobic gram-negative, is of 
major importance with regard to morbidity and mortality, attention currently is 
focused on prevention. However once infected it represents an absolute indication 
for surgical intervention. 
Results of four recently reported clinical trials with intravenolls antimicrobial 
prophylaxis are discussed in detail in chapter 6. In summary, an Italian randomi-
zed multicenter study, with prophylactic imipenem, demonstrated a significant 
reduction of infected pancreatic necrosis'. However, mortality was not reduced. 
In a Finnish study, cefuroxime did not reduce the overall incidence of pancreatic 
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infection', Confounding factors may have been responsible for the reported 
reduction of mortalitylO,ll, A French study using ceftazidime, amikacine and 
metronidazole, reporting a reduction of overall episodes of sepsis did neither 
achieve a reduction of overall nor gram-negative pancreatic infection!2, A well-
designed Gelman study, using ofloxacin and metronidazole, did not demonstrate 
efficacy with regard to prevention of infection of pancreatic necrosis13, Conclusi-
OIlS from the two aforementioned studies have to be interpreted with caution due 
to the small sample size, 
Recently, a Japanese clinical study demonstrated reduction of pancreatic 
infection by continuous regional arterial infusion with imipenem combined with 
nafamostat, a protease inhibitOl.14, However, the simulaneous use of nafamostat, 
a protease inhibitor, may have interfered with the results and the clinical 
applicability of this technique may have its drawback. 
Although results of the four clinical trials with intravenous antimicrobial 
prophylaxis are not all identicaI8,9,!2,13, antibiotics that achieve adequate pancreatic 
tissue levels, such as the third generation cephlosporins, piperacillin, 4-
quinolones, imipenem and metronidazole, may be considered as prophylaxis 
against secondary infectious complications in severe acute pancreatitis!5, 
SELECTIVE DECONTAMINATION TO PREVENT PANCREATIC 
INFECTION: THE RATIONALE 
The microbiology of pancreatic infections in patients with severe acute pancrea-
titis, which yields predominantly aerobic gram-negative micro-organisms, 
provides indirect evidence that these pathogens originate from the digestive 
tract'·6, Colonization of the digestive tract is thought to be the initial step of 
endogenous infection of other major organ systems (e,g, (peri)pancreatic 
necrosis)!6,17, During hospitalization, the digestive tract of more than 60% of the 
patients with severe acute pancreatitis is colonized with nosocomial gram-negative 
flora, usually Pseudomollas aerugillosa and Klebsiella species, as shown in 
chapter 5, Bacterial translocation from the gut towards the pancreas is promoted 
by acute pancreatitis as demonstrated experimentallis,,,, 
Direct clinical evidence demonstrating that aerobic gram-negative infections of 
(peri)pancreatic necrosis are gut-originated is reported in chapter 4, which shows 
that the appearance of gram-negative intestinal colonization (E. coli excepted) 
entails a significantly increased risk of pancreatic infections as well as higher 
mortality, 
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In chapter 5 is shown that selective decontamination of the digestive tract can both 
effectively prevent and reverse gram-negative intestinal colonization in patients 
with severe acute pancreatitis. Reduction of gram-negative intestinal colonization 
decreases the risk to develop a secondary pancreatic infection (chapter 4). The 
development of gram-negative pancreatic infection is the determinant of mortality 
in contrast to patients in whom infection of necrosis does not occur (i.e. 
preservation of sterile necrosis) or to dose who develop an infection with only 
gram-positive bacteria during the course of the disease as shown in chapter 3. 
Mortality is decreased through this reduction of gram-negative infection of 
(peri)pancreatic necrosis as shown in chapter 2. Figure I displays these 
established relations with regard to use of selective decontamination. 
Nosocomial gram-negative flora 
on the intensive care unit 
Gram·negative Infection of 
(perl·)pancreatic necrosis 
Selective Decontamination 
... ., ~ 
Imlpenem (i.v.) ............ -............................................... .. MORTALITY 
Figure 1. Clinical sequence of development of aerobic gram-negative infection, following 
intestinal colonization, of (peri)pancreatic necrosis in patients with severe acute pancreatitis 
including the effect of antibiotic prophylaxis with either selective decontamination or intravenous 
antibiotics, i.e. imipenem. Solid arrows refer to significant relations. Dotted arrows refer to 
possible relations. 
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ANTIMICROBIAL PROPHYLAXIS IN SEVERE ACUTE PANCREATITIS: 
INTRA VENOUS OR ENTERAL? 
Since various possible routes of translocation towards the pancreas are suggested, 
intravenous antibiotics may not effectively combat translocating bacteria on all 
pathways'6. Moreover intravenous antibiotics neither prevent the occurrence of 
gram-negative intestinal colonization nor do they always penetrate sufficiently into 
pancreatic tissue during acute pancreatitis. Although adequate pancreatic tissue 
penetration was demonstrated, imipenem does not always exceed the minimal 
inhibitory concentrations of the most frequently isolated micro-organisms in non-
perfused necrotic (peri)pancreatic tissues as demonstrated by Bassi and co-
workers27 • In accordance with these findings, Foitzik and co-workers demonstrated 
that imipenem, which has a good water solubility but moderate liposolubility, 
accumulates in oedematous peri necrotic tissue during the early phase of the 
disease however that the concentration tends to decrease, already after 48 hours, 
with resolution of the oedema and the progression of acinar cell necrosis later in 
the course of the disease". The latter can also be learned from the results of 
Pederzoli et ai., which show that imipenem did not reduce pancreatic infection in 
patients with substantial amounts of (peri)pancreatic necrosiss. 
Widdison and colleagues demonstrated that early (12 hours from onset) 
administration of intravenous cefotaxime or levamisole in cats was indeed 
effective in treating however ah'eady established pancreatic infection29•30 • MithOfer 
and colleagues reported reduction of early (7 days) pancreatic infection in 
experimental acute pancreatitis in rats, which received prophylactic intravenous 
ciprofloxacin or imipenem as compared to a control group3l. Early mortality was 
reduced only with ciprofloxacin. In human acute pancreatitis however, pancreatic 
infection only plays a minor role with regard to early mortality. Mortality at 21 
days, the end point of the study, was reduced for both treatment groups. However, 
late pancreatic infection was not reduced probably because of the low number of 
control animals alive. Moreover, the high percentage of anaerobic pancreatic 
infection (43%) after 3 weeks does not correspond with findings in human 
pancreatitis and presumably can not be explained by translocation. Araida and co-
workers demonstrated that intravenous ciprofloxacin reduced the incidence of 
pancreatic infection and 24-h mortality". However the antibiotic was given 
simultaneously with the induction of pancreatitis and follow up was very short (24 
hour). 
Drewelow and colleagues confirmed the ability of necrotic pancreatic tissue to 
take up intravenously administered ceftazidime in three patients with acute 
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pancreatitis". Intravenous pefloxacin, which in theory should have better 
pharmocologic properties with regard to concentrations in pancreatic tissue and 
necrosis was not found to be more effective, in fact worse, when compared with 
imipenem in a clinical trial (Bassi et aI., submitted, with permission). Similarly, 
the clinical efficacy of other 4-quinolone class of antibiotics (e.g. ciprofloxacin 
and ofloxacin), as well as third generation cephalosporins (e.g. cefotaxime, 
ceftriaxone, ceftazidime) has not been proven yet in large scale prospective 
clinical studies. However, appropriate studies to define the ideal antibiotic and 
optimal length of prophylaxis would require the ell1'ollment of approximately 
200-300 or more patients and are difficult to undertake!5.].'. 
Finally, these broad spectrum antibiotics may also cause an increase of fungal 
complications as well as selection of resistant nosocOinial micro-organisms, as was 
found by Pederzoli and colleagues in the group treated with imipenem in which 
two infections caused by Citrobacter and one caused by Serratia oecuned, which 
were not found in the control groupS.35. 
Lange and colleagues reported reduced gram-negative septicaemia and mortality 
in experimental acute pancreatitis in rats treated with intestinal lavage combined 
with enteral administration with kanamycin36. Similarly, Isaji and co-workers 
reported reduced pancreatic infection and mortality in mice treated with enteral 
antibiotics37• Marotta and collaegues demonstrated in rats with acute pancreatitis 
that treatment with a daily rifamixin enema significantly reduced pancreatic 
infection and mortality". These results were even better when lactitol, a cathartic, 
was added. However, treatment was started already before inducing acute 
pancreatitis. Gianotti and collaegues have evaluated different regimes of enterally 
administered antibiotics including selective decontamination, the latter which 
consisted of polymyxin B, amphotericin Band amikacin, 12 hours after onset of 
experimental acute pancreatitisJ9 • The survival rate between days 2 and 7 was 
significantly better in the selective decontamination group, but had disappeared 
at day 10. Although after 3 days aerobic gram-negative flora in the caecum was 
reduced in all groups, selection of Pseudomollas occurred in the group that 
received an antibiotic regimen, which was also used as prophylaxis in colorectal 
surgery. Translocation towards the pancreas was only reduced in the rats treated 
with selective decontamination or the same antibiotic combination without 
amphotericin B. However in this latter group intestinal overgrowth and increased 
pancreatic infection with fungi occurred. 
It has been suggested that the beneficial effects of selective decontamination do 
not solely arise from the elimination of pathogenic gram-negative bacteria from 
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the digestive tract but also because of its restorative actions on the intestinal 
mucosa associated immune system, i.e. secretOlY immunoglobulin A (sIgA)40. 
The rationale of administration of enteral antibiotics, i.e. selective decontamina-
tion, through which reduction of pancreatic infection and reduction of mortality 
is achieved was already discussed above. Since the development of gram-negative 
intestinal colonization significantly increases the risk of secondaty infection of 
(peri)pancreatic necrosis, prevention andlor elimination of intestinal gram-
negative pathogens by means of enteral administration of antibiotics, i.e. selective 
decontamination of the digestive tract, seems the most logic measure to nip the 
danger in the bud. Figure I displays these established relations with regard to the 
use of selective decontamination as compared to possible relations with regard to 
the use of intravenous antibiotics, e.g. imipenem. 
The triple regimen of selective decontamination also comprises, however, a 
short-term, systemic prophylaxis, using cefotaxime, to provide additional cover 
during establishment of decontamination of the digestive tract with enteral 
antibiotics. Tllis initial administration of intravenous cefotaxime can not be 
attributed to for the observed differences in morbidity and mortality (chapter 2) 
as was questioned by Johnson" because, also in the control group, more than 70% 
of the gram-negative pancreatic infections developed after the first week. Moreo-
ver Foitzik et al. showed that concentrations of intra pancreatic cefotaxime are 
inadequately low during the early phase (96 hI') of acute experimental pancre-
atitis". They also demonstrated that eat'ly pancreatic infections were reduced only 
when intravenous cefotaxime and enteral antibiotics were combined, i.e. selective 
decontamination (SD)21. Once the gut - the "motor of pancreatic sepsis" - is 
cleared from aerobic gram-negative pathogens by continuous administration of 
enteral antibiotics, i.e. establishment of selective decontanlination, additional use 
of intravenous antibiotics is not neccessary anymore and can be stopped. 
TIMING AND STRATIFICATION 
Since infection of necrosis may occur already during the first week of the disease 
antibiotic prophylaxis should be administered as SOOI1 as possible after admission 
and stratification of severity. 
No finn clinical data exist with regard to the optimal length of antinlicrobial 
prophylaxis in these patients. It may be advocated to continue selective 
decontanlination until the risk of development of infection of pancreatic necrosis 
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is negligible, i.e., extubated and withont supplementary oxygen therapy or 
infusions, on a regular oral diet and mobilized on the ward. 
Only patients with severe acute pancreatitis will benefit from antimicrobial 
prophylaxis, because mild disease has an uneventful course and recovery 
regardless of the type of medical treatment. Early stratification of all patients with 
acute pancreatitis, by means of a multifactorial prognostic score (e.g. Ranson, 
Imrie or APACHE II) as well as contrast-enhanced CT scan, is therefore strongly 
advocated"-4". The Inll'ie (Glasgow) score, identifying severe acute pancreatitis in 
patients with 3 or more positive prognostic signs, proved to be vary valuable in 
tIus respect. Increasing scores were associated with increased incidence of gram-
negative intestinal colonization (chapter 5), increased risk to develop a gram-
negative pancreatic infection (chapter 3), and increased mortality (chapter 2). 
The tlmie score correlates very strongly with mortality. Mortality was 0%, for 
an Imrie score of 0 or I. and gradually increased to 100%, for patients with an 
Imrie score of 7, as shown in chapter 2. Mortality in patients who were found to 
have severe acute pancreatitis according CT cliteria alone (Balthazar grades D or 
E, but Inllie score <3) was less than 5% in both groups (SD and control). Selective 
decontanllnation may not result in additional benefit in such patients. On the other 
hand most patients who presented with Ilmie score >6 died very rapidly due to a 
fulminant course frequently resistant to any type of treatment. Infection of 
pancreatic necrosis also only plays a minor role in case of early death mostly due 
to acute multiple organ failure (chapter 2). Therefore application of selective 
decontanunation of the digestive tract will be most useful in patients with 
intermediate scores (3-6) who sustain the ilutial critical phase of the disease. 
However since the course of the individual patient with severe acute pancreatitis 
may be unpredictable, the aforementioned does not suggest that selective 
decontanunation should be withheld from patients with velY high Inll'ie scores on 
admission. 
CONCLUSIONS AND RECOMMENDATIONS 
The development of secondmy gram-negative infection of (peri)pancreatic 
necrosis in patients with severe acute pancreatitis, which can be expected fol-
lowing the appearance of gram-negative intestinal colonization, is the deternunant 
with regard to outcome. Rectal surveillance cultures proved to be an early 
prognostic parameter in this respect. 
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SD reduces gram-negative intestinal colonization, leading to decreased gram-
negative bacterial translocation into the pancreatic necrosis. Consequently, SD 
reduces mortality in patients with severe acute pancreatitis due to a significant 
reduction of the development of gram-negative infection of pancreatic necrosis. 
However SD is not useful in patients in whom gram-negative pancreatic iIffection 
already exists before, or in whom gram-negative infection develops during SD 
administration. 
In summary, early administration of selective decontamination to patients with 
severe acute pancreatitis, stratified according a multifactorial prognostic score 
(e.g. Inn'ie score ~3), currently is the most effective prophylaxis to reduce both 
infection of (peri)pancreatic necrosis as well as mortality in patients with severe 
acute pancreatitis. 
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SELECTIEVE DARMDECONTAMINATIE BIJ ERNSTIGE ACUTE 
PANCREATITIS: SAMENV ATTING 
III 
Chapter 8 
INTRODUCTIE 
Acute pancreatitis is een acute ontsteking van de alvleesklier (pancreas), die 
gepaard gaat met een variabele weerslag op de omliggende weefsels en organen 
gelegen op afstand (bv, longen, nieren). Ondanks een veelvoud aan oorzaken, 
vertegenwoordigen galsteenlijden en overmatig alcoholgebruik meer dan 75% van 
aile oorzakelijke factoren. 
Volgens de "AtIanta-c1assificatie" voor acute pancreatitis, is er bij ruim drie-
kwart van de patienten sprake van een milde 1'01111 waarbij de functie van organen 
op afstand niet of nauwelijks is aangetast. Het ziektebeloop bij deze patienten is 
meestal ongecompliceerd en zij genezen vrijwel allemaal zonder dat specifieke 
maatregelen, b.v. speciale medicijnen, no dig zijn. Echter gedurende de eerste 24 
a 48 uur na het omstaan van de symptomen welke wijzen op het optreden van een 
acute pancreatitis ontwikkelt zich bij ongeveer 20-30% van de patienten een zeer 
ernstige ontsteking van het pancreas. Deze emstige vOl'm gaat gepaard met 
ernstige functiestoornissen van diverse andere orgaansystemen (Multipel 
OrgaanFalen (MOF)) en/of met locale complicaties zoals het omstaan van 
weefselversterf (necrose), pus- en afgekapselde vochtcollecties (abcessen en 
pseudocysten). Om de ernst van de aandoening in kaart te brengen worden 
laboratorium resultaten en de bevindingen van afbeeldend Riintgen-onderzoek 
(b.v. CT-scan) getoetst aan speciaal hiervoor ontwikkelde prognostische scores. 
Indien gebruik wordt gemaakt van een score welke opgebouwd is uit klinisch 
chemische parameters, wordt gecontroleerd of specifieke "Iab-uitslagen" de 
drempelwaarde, aangegeven door de criteria, welke samen een prognostisch score-
systeem vonnen, al of niet overschrijden. De Imrie score, welke gebruikt werd in 
deze studie, be staat uit 8 afzonderlijke criteria waarop de patient weI (I punt) of 
niet (0) kan scoren. Hoe zieker de patient, des te hoger is de score (maximum 
score=8). Er is sprake van een ernstige acute pancreatitis indien de patient voldoet 
aan 3 of meer criteria. 
INFECTIE VAN PANCREASNECROSE 
Met ontwikkelingen op het gebied van de intensive care geneeskunde, waarbij de 
functie van falende orgaansystemen kunstmatig kan worden ondersteund, 
overleven meer patienten de eerste kritieke fuhninante fase van de ziekte. 
Aangezien de natuurlijke weerstand van de patient ernstig is aangetast door de 
heftige ontsteking van het pancreas dreigt in tweede ins tan tie het gevaar van het 
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optreden van infecties. De (groten)deels afgestorven alvleesklier vormt immel's 
een ideale voedingsbodem voor bacterien die volop aanwezig zijn op de intensive 
care afdeling. Bij meer dan 80% van de patienten die langeI' dan I week 
opgenomenliggen op deze afdeling wordt het spijsverteringskanaal (over)bevolkt 
door deze (hoofdzakelijk gram-negatieve) intensive care bacterien (nosocomiale 
flora), die binnen dringen via natuurlijke openingen (bv. mond of anus), of via 
infuuslijnen, of beademingsbuizen. 
Infectie van afgestorven weefsels in en rond het pancreas «peri)pancreatische 
necrose), welke optreedt in 40-70% van de gevallen, is op dit moment de 
hoofdoorzaak van sterfte bij patienten met ernstige acute pancreatitis. 
HYPOTHESE 
Het klinisch belang van het onderscheid tussen patienten met ernstige acute 
pancreatitis waarbij de (peri)pancreatische necrose al of niet (steriel) ge'infecteerd 
is, werd voor het eerst benadrukt door de collega Beger en medewerkers in een 
publicatie daterend uit 1986. Aan de hand van kweekresultaten van operatief 
verwijderde necrose, werd aangetoond dat het sterftecijfer in geval van 
ge'infecteerde necrose signiilcant hoger was in vergelijking met patienten bij wie 
sprake was van steriele necrose. K walitatieve analyse van de kweekuitslagen 
toonde aan dat in ± 70% gram-negatieve bacterien werden aangetroffen welke, 
zoals reeds hierboven gesteld, vaak voorkomen op de intensive care afdeling en 
ook in het spijsverteringskanaal van ernstige zieke patienten tijdens 
ziekenhuisopname, met name gedurende verblijf op de intensive care unit. 
Selectieve darmdecontaminatie is een antibiotische profylaxe waarbij met 
behulp van een combinatie van een drietal antibiotic a, toegediend via mond en 
anus, gram-negatieve nosocomiale flora (inc!. gisten) selectief worden verwijderd 
uit het darmiumen en waarbij de "eigen" darmflora wordt gespaard. Deze laatste 
vormt een onderdeel van een complex aan factoren welke bij gezonde personen 
weerstand (kolonisatie resistentie) biedt tegen overbevolking door nosocomiale 
flora. Aangezien het enkele dagen kan duren voordat het darmlumen volledig 
selectief is gedecontamineerd wordt bij aanvang een kortstondige aanvullende 
profylaxe met intraveneuze (per infuus) antibiotic a (systelnische profylaxe) 
toegediend. 
Naar aanleiding van de overeenkomst tussen de bacteriele flora zoals aangetrof-
fen in necrose enerzijds en het darmlumen van intensive care patienten anderzijds, 
werd gepostuleerd dat infectie van (peri)pancreatische necrose zou kunnen 
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optreden doordat deze bacteriele flora eerst het spijsverteringskanaal binnendringt 
(kolonisatie) en vervolgens van hieruit migreert (bacteri<~le translokatie), bv. via 
het bloed, lymfebanen, of rechtsreeks door de darmwand via de vlije buikholte, 
naar (peri)pancreatische necrose. 
Door middel van het continu schoonspoelen met een zoutoplossing van dannen 
(intestinale lavage) met daarin een antibioticum bij ratten met ernstige acute 
pancreatitis bereikte collega Lange en medewerkers een belangrijke mortaliteits-
reductie. 
Emstige acute pancreatitis 
1 
Selectieve darmdecontaminatie 
1 
Verwijderen en weren van 
gram-negatieve nosocomiale flora uit het dannlumen 
1 
Behaud van steriele (peri)pancreatische necrose 
1 
Mortaliteitsreductie? 
Figllllr 1. Hypothese 
In tegenstelling tot intestinale lavage is selectieve darmdecontaminatie klinisch 
wei goed toepasbaar bij el11stig zieke patienten. Mede naar aanleiding van resulta-
ten van bovengenoemd dierexperimenteel onderzoek, werd gepostuleerd dat indien 
gram-negatieve nosocomiale flora, middels toe passing van selectieve darm-de-
contaminatie, verwijderd en geweerd kan worden uit het dannlumen van patienten 
met ernstige acute pancreatitis, reductie van infectie van (peri) pancreatische 
necrose zou kllnnen worden bereikt. Indien gram-negatieve infectie van necrose 
inderdaad een belangrijke factor zou zijn met betrekking tot de prognose ZOll 
bovenstaande uiteindelijk moe ten lei den tot mortaliteitsreductie bij deze groep 
patienten (Figuur 1). Deze hypothese is onderzocht in een multicenter trial 
waaraan 16 ziekenhuizen in Nederland hebben deelgenomen. 
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RESULTATEN 
In /lOofdsllIk 2 worden de resultaten van deze illulticentertrial beschreven waarbij 
middels een gecontroleerde studie (vergelijidng met een controle groep) de waarde 
van selectieve darmdecontaminatie (SO) bij 102 patienten met ernstige acute 
pancreatitis is onderzocht. SO als toevoeging aan een standaard optimale en 
intensieve behandeling, resulteerde in een significante reductie van gram-
negatieve pancreasinfecties alsook mortaliteit. Patienten die behandeld werden met 
SO hoefden mindel' vaak opnieuw te worden geopereerd voor het verwijderen van 
(gei'nfecteerde) necrose. In 8% van de patienten trad ondanks behandeling met SO 
toch een gram-negatieve pancreasinfectie op. 
In /lOofdsllIk 3 wordt het sterfterisico berekend afhankelijk van de soort 
pancreasinfectie; gram-positieve, gram-negatieve, en gemengde in vergelijking 
met patienten bij wie geen infectie van (peri)pancreatische necrose (steriele 
necrose) optreedt. Los van het feit dat gei'nfecteerde (ped)pancreatische necrose 
chirurgisch moet worden behandeld geeft de ontwikkeling van gram-negatieve 
pancreasinfectie tijdens het beloop van een ernstige acute pancreatitis een sterk 
verhoogd mortaliteitsrisico ten opzichte van lou tel' gram-positieve infectie of 
steriele necrose. Het omstaan van een pancreasinfectie met louter gram-positieve 
bacterien, waaronder zgn. huidflora, geeft op zichzelf geen aanleiding tot een 
verhoogd sterfterisico ten opzichte van steriele necrose. Een door anderen 
geopperd nadeel als zou SO aanleiding geven tot een verhoogde incidentie van 
gram-positieve infecties wordt in dit onderzoek weerlegd. 
In /lOofdsllIk 4 wordt beschreven dat gram-negatieve pancreasinfecties hun 
oOl'sprong vinden in de darm die gekoloniseerd wordt door nosocomiale gram-
negatieve flora. Het optreden van kolonisatie van de dann tijdens een ernstige 
acute pancreatitis, geeft een significant verhoogd risico op het aansluitend, meestal 
I week later, ontstaan van een gram-negatieve pancreasinfectie en dientengevolge 
een verhoogd illOltaliteitsrisico. Het ontstaan van gram-positieve pancreasinfecties 
worden meestal niet voorafgegaan door kolonisatie van de darm. 
In /lOofdsllIk 5 wordt aangetoond dat SO bij patienten met een ernstige acute 
pancreatitis effectief gram-negatieve nosocOlniale flora elimineelt en weert uit de 
dann. 
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CONCLUSIES 
Het gebruik van SD bij patienten met ernstige acute pancreatitis, direct na het 
stellen van de diagnose, resulteert in een reductie van kolonisatie van de datm met 
gram-negatieve nosocomiale flora. Hierdoor treden mindel' gram-negatieve 
pancreasinfecties op wat, aangezien dit een zeer belangrijke prognostische 
parameter is, leidt tot reductie van morbiditeit en mortaliteit (Figuur 2). 
Nosocomlale gram·negatleve flora 
op de intensive care afdellng 
.... 
G'~",'''~'~/ 
Gram.negatleve Intectle van 
(peri)pancreatlsche necrose 
~ 
Selectieve Decontarninatle 
MORTALITEIT 
Figuur 2. Ontwikkelillg van gram-negatieve infectie van (peri)pancreatische necrose, volgend 
op illtestlnale kolonisatie, bij patienten met emstige acute pancreatitis. De pijlen naar rechts, 
welke samen een cascade vorIllen, duiden achtereenvolgens op een verhoogd tisico op de 
daaropvolgende gebeurtenis. Selectieve decontaminatie (pijlen naar links) resulteert in een 
reductie van gram-negatieve kolollisatie van de dann (dikste pijl), waardoor reductie van 
rcspectievelijk pancreasinfectie en mortaliteit wordt bewerkstel1igd. 
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Gedurende de afgelopen 10 jaar hebben velen bijgedragen aan de opzet en 
uitvoering van de multicentertrial en de aansluitende verwerking van resultaten tot 
het huidige proefschrift waarvoor ik hen zeer veel dank verschuldigd ben. 
Prof.Dr.H.A. Bruining, mijn promotor en opleider, beste Kieje, in mei 1989 
hadden wij het eerste officiele overleg hierover. De besprekingen zowel tijdens het 
beloop van de trial alsook daarna waren zoals ze horen te zijn: kort, to the point, 
zonder onnodige franje en inspirerend. Jouw kritische opstelling en zeker het 
aanvankelijke ogenschijnlijke ongeloof in het welslagen van dit onderzoek, zijn 
voor mij de ultieme drijfveer geweest am te trachten het tegendeel te bewijzen. 
Dr.J.F. Lange, mijn co-promotor, beste Jollal/, met jouw promo tie onderzoek 
werd de basis gelegd voor deze klinische studie. Aan de wasbakken van de OK 
van het St. Clara ziekenhuis ontstonden de plannen voor een multicentertrial. 
Groot was en bleef je aanstekelijk enthousiasme en betrokkenheid. Het door jouw 
geschonken vertrouwen in goede maar oak slechte tijden, is voor mij van grote 
betekenis geweest. 
Dr.W.c'J. Hop, beste Willi, vanaf het allereerste uur tot de laatste correctie ben 
je er zeer intensief bij betrokken geweest. Ontelbare uren en middagen zaten wij 
achterjouw computer, onderwijl zoekend naar en discussierend over de (on)mo-
gelijkheid van causale verbanden in de vele megabytes aan gegevens. Ais 
statisticus leefde jij je ongelooflijk goed in, in deze klinische materie. Jouw 
bijdrage is va or mij van onschatbare waarde geweest en heeft het resultaat naar 
een hoger niveau getild. 
Dr.H.Ph. Endtz, beste Hubert, vooral tijdens de tweede fase van het onderzoek, 
heb ik vaak een gewaardeerd beroep op je mogen doen. 
Prof.Dr.C.W. Imrie, dear Clelll, we first met at the First United European 
Gastroenterology Week in Athens, september 1992, where you invited me to 
present the preliminmy results. Thank you velY much for your sincere interest and 
continuing support. 
Prof.Dr.M. BUchler, lieber Markus, herzlichen Dank fUr deinen wertvollen 
Bemerkungen, fortwuhrendes Interesse und Einladungen fUr verschiedenen 
internationalen Kongressen. 
Prof.Dr.C. Bassi, caro Claudio, amico mio, la ricerca italiana ed ollandese sono 
rivali a livello scientifico. Ti ringrazio molto per il tuo interesse ed i tuoi ottimi 
suggerimenti. 
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Dr.S.J.A. Aerdts. Dr.A.B. Stroebel en Dr.H.J. Mud gaven adviezen tijdens de 
voorbereidingen van de trial. Drs. A.J. Wilhelm, apotheker van het St. Clara 
ziekenhuis werkte mee aan de bereiding van SD die, indien gewenst, binnen 
enkele uren na randomisatie tot in de verste uithoeken van het land werd 
afgeleverd door Freek KUntze. 
De hierna volgende collegae namens de chirurgische maatschappen en van de 
deelnemende ziekenhuizen: Dr.W.F. Eggink (Rijnstate Ziekenhuis Arnhem), 
Dr.A.C. van del' Ham (destijds St. Jansdal Ziekenhuis Harderwijk), Dr.A. Jansen 
(destijds St. Antonius Ziekenhuis Nieuwegein), DrJ.H.C. Kuypers (destijds St. 
Radboud Ziekenhuis Nijmegen) en Dr.A.P.M. Boll (St. Radboud Ziekenhuis 
Nijmegen), DrJ. Lens en Dr.RJ.ThJ. Welten (De Wever Ziekenhuis Heerlen), 
Prof.Dr.H. Obertop en Drs.R. Trompmeesters (destijds Academisch Ziekenhuis 
Utrecht), Dr.H.B. Oeseburg (Martini Ziekenhuis Groningen), Dr.M.K.M. Salu 
(Zuider Ziekenhuis Rotterdam), Dr.H.L. de Smet (St. Maartens Gasthuis Venlo), 
Dr.J.P. Snellen (Kennemer Gasthuis Hamlem), Dr.ThJ. van Straaten (St. Jozef 
Ziekenhuis Veldhoven), Dr.H.F. Veen (Ikazia Ziekenhuis Rotterdam), Dr.W.R. 
Weidema (destijds Reinier de Graaf Gasthuis Delft) en DrJ.C.J. Wereldsma (St. 
Franciscus Gasthuis Rotterdam): zander julJie medewerking was deze trial 
iiberhaupt nooit van de grond gekomen. 
Het verplegend personeel, vooral intensive care, van de deelnemende ziekenhui-
zen (inc1usief het Dijkzigt Ziekenhuis en St. Clara Ziekenhuis Rotterdam) voor 
hun inzet en accuratesse. SD was voor velen van jullie nieuw en gaf een verhoging 
van de werkdruk. Hartelijk dank. 
Diverse chimrgen en assistenten van aile deelnemende centra, bij mij bij naam 
bekend maar hopelijk met begrip niet allen hier vermeld, die hun patienten 
aanmeldden voor randOlnisatie. De telefonistes van de 24 UUl'S boodschappen-
dienst te Amsterdam, die zich in korte tijd zowel de Imrie als Balthazar score eigen 
maakten en van elke gerandomiseerde patient direct de data naar mijn huisadres 
faxten. 
Het monitoren van een multicentertrial was een tweede baan naast mijn 
opleiding tot chirurg. De vele tienduizenden kilometers die per auto werden 
afgelegd maakten efficient en snelwerken tot een bittere noodzaak. Alhoewel de 
meeste afstanden 's avonds werden verreden was een vertrek uit de kliniek voordat 
de collegae naar llUis gingen nogal eens onvermijdelijk. Nooit echter heeft een van 
mijn collegae assistenten hiertegen bezwaren geopperd waarvoor ik hen veel dank 
verschuldigd ben. Zonder iemand te kort te willen doen wil ik met name Geert 
Tetteroo, Robert Pierik en Don Poldermans noemen voor de begeleiding van de 
hial tijdens mijn afwezigheid. 
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Prof.Dr.H.W. Tilanus en DrJJ.B. van Lanschot, beste Hllllg en Jail, tijdens mijn 
laatste jaar in Dijkzigt als junior-staflid op 10 Midden hebben jullie mij de fijne 
kneepjes van de oesophaguschirurgie bijgebracht en was ik tevens in de 
gelegenheid, met jullie waI1ne belangstelling, te werken aan de afronding van het 
belangrijkste hoofdstuk, en artikel, van dit proefschrift. 
Rita Stege heeft als trial-secretaresse bergen werk verzet. 
Henriette Berger-Lahade heeft diverse malen meegeholpen om op lokatie case 
record forms aan de hand van verzamelde patientengegevens in te vullen. 
Jiir van de Wildt (MSD-Haarlem) en Henk Brummehnan (Roussel-Hoevelaken) 
brachten de opzet van de trial onder de aandacht van hun respectievelijke 
werkgevers, maakten deuren open en bleven het beloop van de trial geinteresseerd 
volgen en ondersteunen. 
De sponsors M.S.D. B.V. en Roussel B.V. maakten door middel van hun 
bijdrage de opzet van de P AN.DA-trial (acute PANcreatitis, selectieve DAnn-
decontaminatie) mogelijk. Gerda Gamelkoorn (MSD) en Jacqueline de Leemv 
(Roussel) controleerden de intake in de trial en noteerden eventuele ongewenste 
bijwerkingen van respectievelijk norfloxacin en cefotaxinle. 
Paul, Cees Rein, Tjaarda, Fred, Roland alsook de ex-collegae Karel en Piet maar 
vooral Aldi: als je in zo'n maatschap mag werken val je met je kont in de boter: 
support geldt als vanzelfsprekend en aan interesse voor het onderzoek geen 
gebrek. Valerie van de Wiel, als secretaresse een rots in de branding. 
De medische staf, het personeei en de directie van het St. Anna Ziekenhuis voor 
hun wanne belangstelling. 
Mijn ouders hebben mij inmler gestimuleerd en volgden net zoals mijn broer 
Maarten en zussen Dorien en Rosalie, oma, schoonmoeder en schoonfamilie de 
ontwikkelingen belangstellend. De verdediging van dit proefschrift net zoals de 
voltooiing van zijn eigen levenswerk, de passengers terminal op het nieuwe 
vliegveld van Hong-Kong, kon Maarten helaas niet meemaken .... 
Robert Pierik en Fred van del' Linden dank ik voor hun steun als paranimf. 
Lieve Joy, last but not least, na 10 jaar Iijkt het Panda-onderzoek een deel van 
ons leven te zijn geworden. Zo ooit gesteld, dat een promotietraject voor een 
promovendus vergelijkbaar zou zijn met het rijden van de Elfstedentocht, dan rijdt 
de echtgenote de afstand misschien wei twee maal achter elkaar. Mijn dank voor 
jouw oneindig begrip, steun en vertrouwen zijn niet in woorden weer te geven. 
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CURRICULUM VITAE 
De auteur werd op 11 oktober 1960 geboren te 's Gravenhage. Hij bezocht het 
Rythovius College te Eersel (NB) en behaalde het VWO diploma (Atheneum B) 
in 1979. 
Vanwege uitloting voor de stu die Geneeskunde, als gevolg van de numerus 
fixus, week hij uit naar Belgie. Vanaf 1979 volgde hij de stu die Geneeskunde aan 
de Katholieke Universiteit van Leuven, waarvan het eerste jaar te Kortrijk. Het co-
assistentschap Heelkunde (maart t/mjuni 1985) volgde hij aan de University of 
Colorado (Prof.Dr. E.E. Moore) te Denver (USA) en aan de Thomas Jefferson 
University (Prof. Dr. R. Rosato) te Philadelphia, Pennsylvania (USA). 
Op 26 juni 1986 behaalde hij het diploma in de Genees-, Heel-, en Verloskunde 
(artsexamen) te Leuven met Grote Onderscheiding. 
In juli 1986 behaalde hij het Examination of Medical Sciences (amerikaans 
artsexamen; Medical Doctor) te Brussel onder auspicien van de Educational 
Conullittee for Foreign Medical Graduates. 
Vanaf juli 1986 was hij atts-assistent Heelkunde in opleiding in het ziekenhuis 
Gasthuisberg verbonden aan de Katholieke Universiteit Leuven (Prof.Dr. lA. 
Gruwez). In verband met to elating tot de opleiding Heelkunde na het doorlopen 
van een selectieprocedure onder auspicien van de Nederlandse Vereniging voor 
Heelkunde te Utrecht werd de opleiding in Leuven in december 1986 beeindigd. 
Vanaf 1 jallllat'i 1987 tot en met 31 december 1992 werd hij opgeleid tot chirurg; 
de eerste drie jaar in het SI. Claraziekenhuis te Rotterdam (opleider: Dr. T.I.Yo), 
gevolgd door dtie jaar in het Academisch Ziekenhuis Dijkzigt te Rotterdam 
(hoofd: Prof. Dr. J. Jeekel; op1eider: Prof. Dr. H.A. Bruining). Met ingang van 1 
januari 1993 werd hij geregistreerd als chirurg en was hij als junior-staflid 
verbonden aan de afdeling Heelkunde van het Dijkzigt ziekenllUis te Rotterdam 
waar hij zich toelegde op de oncologische chirurgie (Prof.Dr. H.W. Tilanus). 
Vanaf 1 januari 1994 is hij als vrijgevestigd chirurg werkzaam in het SI. Anna 
ziekenhuis te Geldrop (NB) in associatie met P.R.M. De Bevere, Dr. C.R. van den 
Hoogenband, T.A. Weber, F.Th.P.M. van der Linden, en R.F.T.A. Assmann, 
chirurgen. In december 1996 ontving hij de "Schoemakerprijs 1995" voor de 
publicatie van de onderzoeksresultaten in de Annals of Surgcly. Vanaf juni 1994 
is hij teamarts van het Nederlandse Waterpoloteam Heren, en sedert mei 1998 bij 
de Grand Prix Fonllule-1 autorace te Monte Carlo (Monaco). 
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